SlideShare a Scribd company logo
1 of 33
Download to read offline
LEADING CORPORATION BY VALUE                                                               INDIA-SSA                                                                           PAGE     1
                                                                                         DECEMBER 2010




                                                                                 MONTH                      CUMULATIVE                             12 MONTHS TO DATE
           RANKINGS                                          NO
                                        CORPORATIONS                 Values In               +       Values In            +        Values In           +               %       VALUES
12M        CUM        MON                                    PROD     Crores       %        -%        Crores     %       -%         Crores     %      -%      EVOL     N.P     $ +000
                                                    12M.%

                                     TOTAL MARKET                     4,068.97      100        5.8 46,781.00     100      23.5 46,781.00       100     16.5     100      1.2 1,022,388

       1         1          1      CIPLA                       953      224.84      5.53         5    2,437.01   5.21     21.3      2,437.01   5.21    14.4      98      0.5    53,272
                                 * CIPLA                       953      224.84      5.53         5    2,437.01   5.21     21.3      2,437.01   5.21    14.4      98      0.5    53,272

       2         2          2        RANBAXY*                  651      195.12       4.8       3.8    2,186.16   4.67     17.9      2,186.16   4.67    11.2      95      1.3    47,793
                                 *   CROSLANDS                  85       16.77      0.41      18.4      181.26   0.39     19.7        181.26   0.39    12.8      97      0.1     3,964
                                 *   RANBAXY                   463       85.30       2.1       0.6      981.37    2.1     17.8        981.37    2.1    11.2      95      2.7    21,454
                                 *   RANBAXY GLOBAL CHC         13       28.13      0.69       6.1      289.42   0.62     30.6        289.42   0.62    23.4     106      0.6      6329
                                 +   REXCEL                     26       25.22      0.62       4.3      281.05    0.6     15.5        281.05    0.6       9      94              6,139
                                     SOLUS                      33        4.55      0.11       6.3       52.30   0.11      6.6         52.30   0.11     0.4      86              1,143
                                     STANCARE                   31       35.15      0.86       3.2      400.77   0.86     12.5        400.77   0.86       6      91               8763

       3         3          3      GLAXOSMITHKLINE*            180      169.81      4.17       2.5    1,979.41   4.23     20.3      1,979.41   4.23    13.6      97      0.1    43,258
                                 * GLAXOSMITHKLINE             172      167.43      4.11       2.7    1,947.75   4.16     20.6      1,947.75   4.16    13.8      98      0.1    42,567
                                   GSK CONSUMER HC               8        2.38      0.06     -11.5       31.66   0.07      7.6         31.66   0.07     1.5      87                692

       4         4          4      PIRAMALHEALTHCARE*          783      163.73      4.02       2.9    1,892.24   4.04         18    1,892.24   4.04    11.4      96      1.3    41,352
                                 * PIRAMAL HEALTHCARE          783      163.73      4.02       2.9    1,892.24   4.04         18    1,892.24   4.04    11.4      96      1.3    41,352

       5         5          6      ZYDUS CADILA*               777      153.02      3.76       4.4    1,747.47   3.74     24.7      1,747.47   3.74    17.7     101      1.2    38,192
                                 * GERMAN REMEDIES             268       45.54      1.12      -3.5      512.83    1.1     20.6        512.83    1.1    13.8      98      1.1    11,208
                                 * LIVA HEALTHCARE              53       10.04      0.25      22.3       91.78    0.2     33.9         91.78    0.2    26.7     109      0.8     2,007
                                   RECON                        16        0.00         0     -87.7        0.13      0      7.3          0.13      0     2.3      88                  3
                                 * ZYDUS CADILA                440       97.45      2.39       6.9    1,142.73   2.44     25.9      1,142.73   2.44    18.8     102      1.3     24974
                                                     21.89
       6         6          5      SUN*                        549      156.91      3.86      11.3    1,717.38   3.67     25.5      1,717.38   3.67    18.4     102      0.9    37,542
                                   MILMET LABS                  21        2.55      0.06        13       28.24   0.06     18.7         28.24   0.06    11.9      96                617
                                   SOLARES                      24        3.58      0.09      -4.9       36.18   0.08     12.9         36.18   0.08     6.8      92                791
                                 * SUN PHARMA                  504      150.79      3.71      11.7    1,652.97   3.53       26      1,652.97   3.53    18.8     102      0.9    36,134

       7         7          9      ALKEM*                      708      126.17       3.1       1.3    1,544.73    3.3     26.3      1,544.73    3.3    19.3     102      1.4     33754
                                 * ALKEM                       555      110.96      2.73       1.1    1,348.83   2.88     25.7      1,348.83   2.88    18.7     102      1.4    29,474
                                 * CACHET                       85        9.18      0.23      -2.1      125.71   0.27     32.1        125.71   0.27    24.8     107        1      2746
                                 * INDCHEMIE                    68        6.03      0.15      11.7       70.19   0.15     28.8         70.19   0.15    21.6     104      1.4     1,533

       8         8          8      MANKIND                     507      126.84      3.12      12.3    1,480.26   3.16     41.6      1,480.26   3.16    33.8     115      2.3    32,347
                                 * MANKIND                     507      126.84      3.12      12.3    1,480.26   3.16     41.6      1,480.26   3.16    33.8     115      2.3    32,347

       9         9          10     PFIZER*                     149      119.90      2.95       1.4    1,474.28   3.15     27.9      1,474.28   3.15    20.7     104      0.4    32,224
                                   PARKE DAVIS                  30       13.32      0.33       6.1      165.40   0.35     26.3        165.40   0.35    19.2     102              3,614
                                 * PFIZER                       45       58.51      1.44      -7.4      768.23   1.64       29        768.23   1.64    21.7     104      0.4     16791




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                 INDIA-SSA                                                                               PAGE     2
                                                                                           DECEMBER 2010




                                                                                   MONTH                      CUMULATIVE                               12 MONTHS TO DATE
           RANKINGS                                          NO
                                       CORPORATIONS                    Values In               +       Values In            +        Values In              +              %         VALUES
12M        CUM        MON                                    PROD       Crores       %        -%        Crores     %       -%         Crores     %         -%      EVOL    N.P       $ +000
                                                  12M.%
                                   PHARMACIA                      25        8.01       0.2      -3.1       98.82   0.21     26.2         98.82   0.21       19.2     102               2,160
                                   PHARMACIA HEALTH               13        6.08      0.15      11.8       62.10   0.13     28.3         62.10   0.13       21.2     104                1357
                                 * WYETH LIMITED                  36       33.99      0.84      17.8      379.73   0.81     26.7        379.73   0.81       19.4     103     0.8        8301

      10         10         7      ABBOTT*                     140        127.96      3.14      20.3    1,387.98   2.97     33.4      1,387.98   2.97       25.8     108       1      30,345
                                 * ABBOTT                      113        105.89       2.6      19.2    1,145.91   2.45       33      1,145.91   2.45       25.5     108     1.2      25,054
                                 * SOLVAY PHARMA                27         22.07      0.54      25.9      242.07   0.52     34.9        242.07   0.52       27.2     109     0.1       5,291
                                                     38.15
      11         11         11     LUPIN LIMITED               603        113.63      2.79       7.1    1,272.88   2.72     22.8      1,272.88   2.72       15.9      99     2.2       27818
                                 * LUPIN LIMITED               603        113.63      2.79       7.1    1,272.88   2.72     22.8      1,272.88   2.72       15.9      99     2.2      27,818

      12         12         15     ARISTO PHARMA*              253         88.74      2.18      -3.8    1,122.65    2.4     23.1      1,122.65    2.4       16.2     100     0.9      24,530
                                 * ARISTO PHARMA               154         73.96      1.82      -4.1      940.08   2.01     23.8        940.08   2.01       16.9     100     0.8       20541
                                 * GENETICA                     99         14.77      0.36      -2.3      182.57   0.39     19.3        182.57   0.39       12.5      97     1.4       3,989

      13         13         12     INTAS PHARMA*               773         96.64      2.38      25.3    1,022.38   2.19       39      1,022.38   2.19       31.2     113     1.6      22,350
                                   ANDRE LABS                   17          0.93      0.02      -2.3       10.94   0.02      8.2         10.94   0.02          2      88                 239
                                 * INTAS                       756         95.71      2.35      25.6    1,011.44   2.16     39.5      1,011.44   2.16       31.7     113     1.6      22,111

      14         14         13     DR REDDYS LABS              264         89.89      2.21       1.9    1,013.77   2.17     18.9      1,013.77   2.17       12.2      96         1     22149
                                 * DR REDDYS LABS              264         89.89      2.21       1.9    1,013.77   2.17     18.9      1,013.77   2.17       12.2      96         1    22,149

      15         15         16     SANOFI AVENTIS*             128         88.51      2.18       6.5    1,008.92   2.16     27.6      1,008.92   2.16       20.4     103     1.1       22053
                                 * SANOFI AVENTIS               94         85.05      2.09       9.2      967.86   2.07     29.5        967.86   2.07       22.2     105     1.2      21,156
                                 + SANOFI PASTEUR               18          3.27      0.08       -24       36.36   0.08      0.4         36.36   0.08       -5.2      81                 795
                                 + SHANTHA BIOTECH              16          0.18         0     -79.1        4.70   0.01    -34.4          4.70   0.01      -37.8      53                 102
                                                  49.78
      16         16         19     EMCURE*                     437         81.58         2      13.9      952.02   2.04     26.2        952.02   2.04         19     102     1.8      20,805
                                 * EMCURE                      295         51.49      1.27        21      592.41   1.27     27.3        592.41   1.27         20     103     1.6      12,948
                                 * ZUVENTUS PHARMA             142         30.08      0.74       3.4      359.61   0.77     24.3        359.61   0.77       17.4     101     2.3       7,857

      17         17         14     MACLEODS PHARMA             282         88.86      2.18      31.7      941.05   2.01     47.6        941.05   2.01       39.4     120     3.1      20,574
                                 * MACLEODS PHARMA             282         88.86      2.18      31.7      941.05   2.01     47.6        941.05   2.01       39.4     120     3.1       20574

      18         18         18     TORRENT PHARMA              378         83.67      2.06      12.7      933.62       2        23      933.62        2     15.9      99     1.6      20,410
                                 * TORRENT PHARMA              378         83.67      2.06      12.7      933.62       2        23      933.62        2     15.9      99     1.6       20410

      19         19         17     WOCKHARDT-MERIND*           480         84.25      2.07      11.5      922.44   1.97     20.4        922.44   1.97       13.5      97     0.7      20,162
                                   DUMEX                        23          1.81      0.04     -12.4       25.93   0.06     51.9         25.93   0.06       43.7     123                 567
                                 + MERIND                       72         15.24      0.37      -6.2      185.57    0.4     12.4        185.57    0.4          6      91                4056
                                 * WOCKHARDT                   385         67.20      1.65      17.4      710.94   1.52     21.7        710.94   1.52       14.7      98     0.9      15,540

      20         20         20     ALEMBIC                     356         75.09      1.85      -2.4      843.42    1.8     15.2        843.42       1.8     8.8      93     0.8       18430




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                   INDIA-SSA                                                                                 PAGE     3
                                                                                             DECEMBER 2010




                                                                                     MONTH                        CUMULATIVE                             12 MONTHS TO DATE
           RANKINGS                                            NO
                                         CORPORATIONS                    Values In                +        Values In            +      Values In              +                %         VALUES
12M        CUM        MON                                      PROD       Crores       %         -%         Crores     %       -%       Crores     %         -%        EVOL    N.P       $ +000
                                                     12M.%
                                 * ALEMBIC                       356         75.09      1.85      -2.4        843.42    1.8     15.2      843.42       1.8     8.8        93     0.8      18,430
                                                        59.6
      21         21         23     MICRO LABS*                   654         72.63      1.78       4.5        817.39   1.75     18.4      817.39   1.75       11.8        96     1.3       17861
                                 * BAL PHARMA                     86          2.30      0.06     -17.5         27.54   0.06     -9.5       27.54   0.06      -14.6        73     0.3         602
                                 * MICRO LABS                    568         70.33      1.73       5.4        789.85   1.69     19.7      789.85   1.69         13        97     1.3      17,259

      22         22         21     NOVARTIS INTL.*               202         74.09      1.82       6.6        806.42   1.72     24.8      806.42   1.72       17.7       101     0.2       17628
                                 * NOVARTIS                      103         65.80      1.62       8.3        708.84   1.52       27      708.84   1.52       19.8       103     0.2      15,496
                                 * SANDOZ                         99          8.29       0.2      -5.4         97.58   0.21     10.5       97.58   0.21        4.2        89     0.2       2,133

      23         23         22     USV                           171         73.17         1.8    17.2        787.81   1.68     29.4      787.81   1.68       22.1       105     0.7      17,220
                                 * USV                           171         73.17         1.8    17.2        787.81   1.68     29.4      787.81   1.68       22.1       105     0.7      17,220

      24         24         26     FDC                           213         58.36      1.43     -11.4        775.60   1.66     22.6      775.60   1.66       15.7        99     0.9       16949
                                 * FDC                           213         58.36      1.43     -11.4        775.60   1.66     22.6      775.60   1.66       15.7        99     0.9      16,949

      25         25         24   GLENMARK PHARMA                 240         68.22      1.68      15.5        718.92   1.54     31.4      718.92   1.54           24     106     2.3       15712
                               * GLENMARK PHARMA                 240         68.22      1.68      15.5        718.92   1.54     31.4      718.92   1.54           24     106     2.3      15,712
                                                67.95
      26         26         25   UNICHEM*                        275         60.82      1.49       6.9        702.75    1.5     23.3      702.75    1.5       16.3       100     0.9       15357
                               * UNICHEM                         247         39.33      0.97       6.9        455.96   0.97     24.8      455.96   0.97       17.8       101     1.2       9,963
                               * UNISEARCH                        28         21.48      0.53         7        246.80   0.53     20.5      246.80   0.53       13.6        97     0.3       5,394

      27         27         27     IPCA LABS                     211         50.92      1.25       1.7        675.53   1.44     29.6      675.53   1.44       22.4       105         1    14,757
                                 * IPCA LABS                     211         50.92      1.25       1.7        675.53   1.44     29.6      675.53   1.44       22.4       105         1    14,757

      28         28         28     ELDER PHARMA                  303         44.25      1.09      13.4        498.33   1.07     36.7      498.33   1.07       29.2       111     4.4      10,892
                                 * ELDER PHARMA                  303         44.25      1.09      13.4        498.33   1.07     36.7      498.33   1.07       29.2       111     4.4      10,892

      29         29         29     FRANCO INDIAN                    84       37.47      0.92       3.7        419.21    0.9     17.5      419.21       0.9        11      95     1.7       9,159
                                 * FRANCO INDIAN                    84       37.47      0.92       3.7        419.21    0.9     17.5      419.21       0.9        11      95     1.7       9,159

      30         30         30     MERCK LIMITED                 112         34.38      0.84          10      415.08   0.89     27.2      415.08   0.89           20     103     0.9       9,068
                                 * MERCK LIMITED                 112         34.38      0.84          10      415.08   0.89     27.2      415.08   0.89           20     103     0.9       9,068
                                                     73.74
      31         31         33     CADILA PHARMA                 398         31.63      0.78      -3.4        408.16   0.87     18.2      408.16   0.87       11.4        96     0.4       8,922
                                 * CADILA PHARMA                 398         31.63      0.78      -3.4        408.16   0.87     18.2      408.16   0.87       11.4        96     0.4       8,922

      32         32         32     MSD PHARMACEUTICAL               80       32.86      0.81      -7.4        405.89   0.87     16.4      405.89   0.87        9.9        94     0.4       8,869
                                 + FULFORD INDIA                    30       10.92      0.27     -13.9        138.74    0.3      4.4      138.74    0.3       -1.5        85               3,031
                                 * MSD PHARMACEUTICAL               10       10.24      0.25       7.3        123.36   0.26     68.5      123.36   0.26       59.8       137     1.5       2,696
                                 + ORGANON                          40       11.69      0.29     -11.9        143.79   0.31      0.8      143.79   0.31       -4.9        82                3142




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                INDIA-SSA                                                                               PAGE     4
                                                                                          DECEMBER 2010




                                                                                  MONTH                      CUMULATIVE                               12 MONTHS TO DATE
           RANKINGS                                         NO
                                       CORPORATIONS                   Values In                +      Values In            +        Values In              +                %       VALUES
12M        CUM        MON                                   PROD       Crores       %         -%       Crores     %       -%         Crores     %         -%        EVOL    N.P     $ +000
                                                    12M.%
      33         33         31     INDOCO*                    309         33.56      0.82      -4.4      404.63   0.86       19        404.63   0.86       12.5        97     0.9     8,838
                                 * INDOCO                     264         27.19      0.67      -7.1      332.24   0.71     18.4        332.24   0.71       11.9        96       1     7,256
                                 * WARREN                      45          6.37      0.16         9       72.39   0.15     21.9         72.39   0.15       14.9        99     0.1      1582

      34         34         34     HIMALAYA DRUG              108         31.10      0.76       6.4      366.92   0.78         21      366.92   0.78       14.1        98     0.3     8,020
                                 * HIMALAYA DRUG              108         31.10      0.76       6.4      366.92   0.78         21      366.92   0.78       14.1        98     0.3      8020

      35         35         35     ASTRAZENECA                   57       26.58      0.65       8.6      273.49   0.58     20.8        273.49   0.58           14      98     0.9     5,979
                                 * ASTRAZENECA                   57       26.58      0.65       8.6      273.49   0.58     20.8        273.49   0.58           14      98     0.9      5979
                                                    77.72
      36         36         36     BLUE CROSS                 144         23.76      0.58       9.4      262.14   0.56         26      262.14   0.56       19.1       102     1.4     5,727
                                 * BLUE CROSS                 144         23.76      0.58       9.4      262.14   0.56         26      262.14   0.56       19.1       102     1.4      5727

      37         37         37     UNIQUE PHARM               126         20.41         0.5     6.8      246.75   0.53     23.4        246.75   0.53       16.4       100     0.4     5,392
                                 * UNIQUE PHARM               126         20.41         0.5     6.8      246.75   0.53     23.4        246.75   0.53       16.4       100     0.4      5392

      38         38         39     BIOCHEM                    293         19.02      0.47       0.8      231.38   0.49     28.2        231.38   0.49           21     104     0.4     5,058
                                 * BIOCHEM                    293         19.02      0.47       0.8      231.38   0.49     28.2        231.38   0.49           21     104     0.4      5058

      39         39         41     MEDLEY PHARMA              246         17.11      0.42      -1.3      228.78   0.49     29.6        228.78   0.49       22.4       105     0.5     4,998
                                 * MEDLEY PHARMA              246         17.11      0.42      -1.3      228.78   0.49     29.6        228.78   0.49       22.4       105     0.5      4998

      40         40         38     WIN MEDICARE                  59       19.49      0.48       9.7      220.54   0.47     32.9        220.54   0.47       25.5       108     0.1     4,819
                                 * WIN MEDICARE                  59       19.49      0.48       9.7      220.54   0.47     32.9        220.54   0.47       25.5       108     0.1      4819
                                                    80.26
      41         41         42     RAPTAKOS BRETT                62       16.82      0.41       4.2      218.03   0.47     18.8        218.03   0.47           12      96             4,764
                                   RAPTAKOS BRETT                62       16.82      0.41       4.2      218.03   0.47     18.8        218.03   0.47           12      96              4764

      42         42         40     WALLACE                    104         17.70      0.44      11.7      210.69   0.45         29      210.69   0.45       21.6       104     1.4     4,604
                                 * WALLACE                    104         17.70      0.44      11.7      210.69   0.45         29      210.69   0.45       21.6       104     1.4      4604

      43         43         45     SHREYA LIFE SCIENC         222         15.22      0.37     -10.3      197.40   0.42        6        197.40   0.42          0        86     0.4     4,312
                                 * PLETHICO                   128          7.33      0.18     -17.3       95.95   0.21      3.9         95.95   0.21       -1.8        84     0.7      2096
                                 * SHREYA LIFESCIENCE          94          7.89      0.19      -2.7      101.45   0.22        8        101.45   0.22        1.8        87       0     2,217

      44         44         43     JANSSEN-CILAG                 40       16.41         0.4    10.3      190.12   0.41     25.4        190.12   0.41       18.3       102     1.6     4,155
                                 * JANSSEN-CILAG                 40       16.41         0.4    10.3      190.12   0.41     25.4        190.12   0.41       18.3       102     1.6      4155

      45         45         52     WANBURY                       82       12.76      0.31     -20.1      186.39    0.4     19.5        186.39       0.4    12.9        97     3.9     4,072
                                 * WANBURY                       82       12.76      0.31     -20.1      186.39    0.4     19.5        186.39       0.4    12.9        97     3.9      4072
                                                   82.4
      46         46         50     MANEESH PHARMA*            202         13.62      0.33      -4.4      175.60   0.38       13        175.60   0.38        6.7        92     0.3     3,836
                                 + MANEESH HEALTHCARE          72          2.91      0.07     -13.7       37.07   0.08      3.3         37.07   0.08       -2.5        84               810




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                INDIA-SSA                                                                               PAGE     5
                                                                                          DECEMBER 2010




                                                                                  MONTH                      CUMULATIVE                             12 MONTHS TO DATE
           RANKINGS                                         NO
                                       CORPORATIONS                   Values In                +      Values In            +      Values In              +                %         VALUES
12M        CUM        MON                                   PROD       Crores       %         -%       Crores     %       -%       Crores     %         -%        EVOL    N.P       $ +000
                                                  12M.%
                                   SMYLE                        2          0.06         0     -40.5        1.11      0     -6.4        1.11      0      -11.5        76                  24
                                 * SVIZERA HEALTHCARE         128         10.65      0.26      -1.1      137.42   0.29     16.2      137.42   0.29        9.7        94     0.4       3,002

      47         47         46     PANACEA BIOTEC             146         15.06      0.37       1.7      173.94   0.37     14.6      173.94   0.37        8.1        93     1.3       3,801
                                 * PANACEA BIOTEC             146         15.06      0.37       1.7      173.94   0.37     14.6      173.94   0.37        8.1        93     1.3       3,801

      48         48         44     HETERO HEALTHCARE*         118         15.96      0.39      12.9      173.39   0.37     23.5      173.39   0.37       16.7       100       4       3,788
                                 * GENIX                       48          6.41      0.16      31.1       65.79   0.14     40.9       65.79   0.14       33.1       114     2.4        1437
                                 * HETERO HEALTHCARE           70          9.56      0.23       3.2      107.60   0.23     14.8      107.60   0.23        8.5        93     5.1       2,350

      49         49         47     MEYER ORGANICS             110         14.54      0.36      15.8      167.82   0.36     33.1      167.82   0.36       25.7       108     1.6       3,667
                                 * MEYER ORGANICS             110         14.54      0.36      15.8      167.82   0.36     33.1      167.82   0.36       25.7       108     1.6       3,667

      50         50         49     APEX                          72       13.78      0.34       5.7      163.53   0.35     21.1      163.53   0.35       14.4        98         0     3,573
                                 * APEX                          72       13.78      0.34       5.7      163.53   0.35     21.1      163.53   0.35       14.4        98         0      3573
                                                    84.23
      51         51         54     ALBERT DAVID                  72       12.39         0.3    14.8      156.19   0.33     21.6      156.19   0.33       14.6        98     0.6       3,414
                                 * ALBERT DAVID                  72       12.39         0.3    14.8      156.19   0.33     21.6      156.19   0.33       14.6        98     0.6        3414

      52         52         51     SYSTOPIC                   104         13.01      0.32      15.9      147.51   0.32     32.8      147.51   0.32       25.2       107     1.2       3,224
                                 * SYSTOPIC                   104         13.01      0.32      15.9      147.51   0.32     32.8      147.51   0.32       25.2       107     1.2       3,224

      53         53         48     CENTAUR                    114         13.85      0.34      -2.1      144.16   0.31     17.6      144.16   0.31       11.2        95     0.7        3149
                                 * CENTAUR                    114         13.85      0.34      -2.1      144.16   0.31     17.6      144.16   0.31       11.2        95     0.7       3,149

      54         54         60     GENO                          56       11.21      0.28       2.6      141.80    0.3     38.4      141.80       0.3    30.7       112         1      3098
                                 * GENO                          56       11.21      0.28       2.6      141.80    0.3     38.4      141.80       0.3    30.7       112         1     3,098

      55         55         55     DABUR                      372         12.25         0.3   -19.5      141.13    0.3    -11.5      141.13       0.3   -16.6        72     0.1        3085
                                 * DABUR                      372         12.25         0.3   -19.5      141.13    0.3    -11.5      141.13       0.3   -16.6        72     0.1       3,085
                                                    85.79
      56         56         53     FOURTS INDIA               122         12.56      0.31      13.1      140.43    0.3     22.5      140.43       0.3    15.5        99     1.4        3069
                                 * FOURTS INDIA               122         12.56      0.31      13.1      140.43    0.3     22.5      140.43       0.3    15.5        99     1.4       3,069

      57         57         61     IND-SWIFT                  453         10.83      0.27     -17.4      138.94    0.3      4.9      138.94       0.3        -1      85     0.9        3036
                                 * IND-SWIFT                  453         10.83      0.27     -17.4      138.94    0.3      4.9      138.94       0.3        -1      85     0.9       3,036

      58         58         64     BESTOCHEM                  147          9.99      0.25      -2.9      134.46   0.29     22.8      134.46   0.29       15.9        99     2.3        2937
                                 * BESTOCHEM                  147          9.99      0.25      -2.9      134.46   0.29     22.8      134.46   0.29       15.9        99     2.3       2,937

      59         59         57     ELI LILLY                     22       11.76      0.29       8.4      129.38   0.28     23.7      129.38   0.28       16.7       100         0      2828
                                 * ELI LILLY                     22       11.76      0.29       8.4      129.38   0.28     23.7      129.38   0.28       16.7       100         0     2,828




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                INDIA-SSA                                                                                  PAGE     6
                                                                                          DECEMBER 2010




                                                                                  MONTH                       CUMULATIVE                               12 MONTHS TO DATE
           RANKINGS                                         NO
                                         CORPORATIONS                 Values In                +       Values In            +        Values In              +                %         VALUES
12M        CUM        MON                                   PROD       Crores       %         -%        Crores     %       -%         Crores     %         -%        EVOL    N.P       $ +000
                                                   12M.%
      60         60         63     ALLERGAN                      43       10.35      0.25      15.7       123.49   0.26     37.1        123.49   0.26       29.3       111     4.7        2700
                                 * ALLERGAN                      43       10.35      0.25      15.7       123.49   0.26     37.1        123.49   0.26       29.3       111     4.7       2,700
                                                    87.22
      61         61         56     HEGDE & HEGDE                 46       11.88      0.29      19.4       122.92   0.26     35.8        122.92   0.26       28.4       110                2687
                                   HEGDE & HEGDE                 46       11.88      0.29      19.4       122.92   0.26     35.8        122.92   0.26       28.4       110               2,687

      62         62         58     AJANTA PHARMA              147         11.51      0.28      13.3       122.74   0.26     19.2        122.74   0.26       12.3        96     2.9        2684
                                 * AJANTA PHARMA              147         11.51      0.28      13.3       122.74   0.26     19.2        122.74   0.26       12.3        96     2.9       2,684

      63         63         67     CFL                           98        9.52      0.23      -5.9       121.28   0.26      5.1        121.28   0.26           -1      85     0.4        2650
                                 * CFL                           98        9.52      0.23      -5.9       121.28   0.26      5.1        121.28   0.26           -1      85     0.4       2,650

      64         64         65     CHARAK PHARMA                 60        9.93      0.24      -0.1       121.00   0.26     15.6        121.00   0.26        9.1        94         0      2643
                                 * CHARAK PHARMA                 60        9.93      0.24      -0.1       121.00   0.26     15.6        121.00   0.26        9.1        94         0     2,643

      65         65         59   ORCHID CHEM&PHARM*           172         11.29      0.28       9.5       120.76   0.26     17.7        120.76   0.26           11      95     1.2        2639
                               * ORCHID CHEM&PHARMA           172         11.29      0.28       9.5       120.76   0.26     17.7        120.76   0.26           11      95     1.2       2,639
                                                88.52
      66         66         66   MODI MUNDIPHARMA                31        9.84      0.24     -11.8       116.37   0.25     10.8        116.37   0.25        4.5        90     0.1        2543
                               * MODI MUNDIPHARMA                31        9.84      0.24     -11.8       116.37   0.25     10.8        116.37   0.25        4.5        90     0.1       2,543

      67         67         73     EAST INDIA                    34        7.69      0.19          0      105.85   0.23     27.7        105.85   0.23       20.4       103         0      2313
                                 * EAST INDIA                    34        7.69      0.19          0      105.85   0.23     27.7        105.85   0.23       20.4       103         0     2,313

      68         68         69     JAGSON PAL                    88        8.51      0.21      -7.4       103.52   0.22         17      103.52   0.22       10.3        95                2262
                                 + JAGSON PAL                    88        8.51      0.21      -7.4       103.52   0.22         17      103.52   0.22       10.3        95               2,262

      69         69         62     BAIDYANATH                 333         10.37      0.25       3.7       102.81   0.22     23.9        102.81   0.22       17.2       101         0      2248
                                 * BAIDYANATH                 333         10.37      0.25       3.7       102.81   0.22     23.9        102.81   0.22       17.2       101         0     2,248

      70         70         70     SERDIA                        11        8.36      0.21       9.9        97.76   0.21     31.6         97.76   0.21       24.1       107                2136
                                 + SERDIA                        11        8.36      0.21       9.9        97.76   0.21     31.6         97.76   0.21       24.1       107               2,136
                                                    89.64
      71         71         68     UNIVERSAL                     56        8.74      0.21       8.7        96.47   0.21     14.8         96.47   0.21        8.2        93     0.3        2108
                                 * UNIVERSAL                     56        8.74      0.21       8.7        96.47   0.21     14.8         96.47   0.21        8.2        93     0.3       2,108

      72         72         72     BIOLOGICAL E                  65        7.75      0.19     -11.9        95.34    0.2      6.9         95.34       0.2     0.9        87     0.5        2083
                                 * BIOLOGICAL E                  65        7.75      0.19     -11.9        95.34    0.2      6.9         95.34       0.2     0.9        87     0.5       2,083

      73         73         71     UCB PHARMA                    19        7.95         0.2    10.6        83.16   0.18     22.4         83.16   0.18       15.6        99         4      1818
                                 * UCB PHARMA                    19        7.95         0.2    10.6        83.16   0.18     22.4         83.16   0.18       15.6        99         4     1,818

      74         74         74     BIOCON                        50        7.53      0.18      19.5        82.74   0.18     25.2         82.74   0.18           18     101     3.6        1808




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                 INDIA-SSA                                                                               PAGE     7
                                                                                           DECEMBER 2010




                                                                                   MONTH                       CUMULATIVE                             12 MONTHS TO DATE
           RANKINGS                                          NO
                                       CORPORATIONS                    Values In               +        Values In            +        Values In           +                %         VALUES
12M        CUM        MON                                    PROD       Crores       %        -%         Crores     %       -%         Crores     %      -%        EVOL    N.P       $ +000
                                                     12M.%
                                 * BIOCON                         50        7.53      0.18      19.5        82.74   0.18     25.2         82.74   0.18        18     101     3.6       1,808

      75         75         90     DEY S                          46        5.29      0.13      -8.9        80.64   0.17     12.6         80.64   0.17     6.2        91     0.7        1762
                                 * DEY S                          46        5.29      0.13      -8.9        80.64   0.17     12.6         80.64   0.17     6.2        91     0.7       1,762
                                                     90.58
      76         76         79     TABLETS INDIA                  84        6.62      0.16         -6       77.61   0.17     24.1         77.61   0.17    17.3       101     0.4        1696
                                 * TABLETS INDIA                  84        6.62      0.16         -6       77.61   0.17     24.1         77.61   0.17    17.3       101     0.4       1,696

      77         77         76     SERUM INSTITUTE                66        7.01      0.17      19.5        77.03   0.16     18.7         77.03   0.16        12      96         2      1683
                                 * SERUM INSTITUTE                66        7.01      0.17      19.5        77.03   0.16     18.7         77.03   0.16        12      96         2     1,683

      78         78         83     JOHNSON & JOHNSON              48        6.08      0.15     -18.5        75.90   0.16      5.4         75.90   0.16     -0.5       85                1659
                                 + JOHNSON & JOHNSON              48        6.08      0.15     -18.5        75.90   0.16      5.4         75.90   0.16     -0.5       85               1,659

      79         79         78     TTK HEALTHCARE LTD             81        6.67      0.16      10.3        74.77   0.16     24.3         74.77   0.16    17.2       101     1.8        1634
                                 * TTK HEALTHCARE LTD             81        6.67      0.16      10.3        74.77   0.16     24.3         74.77   0.16    17.2       101     1.8       1,634

      80         80         77     PHARMED                        68        6.81      0.17      28.9        74.73   0.16         34       74.73   0.16    26.4       108     4.5        1633
                                 * PHARMED                        68        6.81      0.17      28.9        74.73   0.16         34       74.73   0.16    26.4       108     4.5       1,633
                                                     91.39
      81         81         75     PARAS PHARMA                   27        7.13      0.18       0.5        74.62   0.16      3.2         74.62   0.16     -2.5       84     0.1        1630
                                 * PARAS PHARMA                   27        7.13      0.18       0.5        74.62   0.16      3.2         74.62   0.16     -2.5       84     0.1       1,630

      82         82         82     TROIKAA PHARMA              144          6.37      0.16       8.4        74.52   0.16         40       74.52   0.16    32.3       114     5.2        1628
                                 * TROIKAA PHARMA              144          6.37      0.16       8.4        74.52   0.16         40       74.52   0.16    32.3       114     5.2       1,628

      83         83         88     WALTER BUSHNELL                22        5.52      0.14      -0.4        71.98   0.15     16.4         71.98   0.15     9.8        94                1573
                                   WALTER BUSHNELL                22        5.52      0.14      -0.4        71.98   0.15     16.4         71.98   0.15     9.8        94               1,573

      84         84         87     ANGLO FRENCH DRUGS             91        5.63      0.14     -14.9        71.89   0.15      9.6         71.89   0.15     3.4        89     0.5        1571
                                 * ANGLO FRENCH DRUGS             91        5.63      0.14     -14.9        71.89   0.15      9.6         71.89   0.15     3.4        89     0.5       1,571

      85         85         80   RPG LIFE SCIENCES             186          6.58      0.16      31.4        70.64   0.15     21.5         70.64   0.15    14.4        98     2.2        1544
                               * RPG LIFE SCIENCES             186          6.58      0.16      31.4        70.64   0.15     21.5         70.64   0.15    14.4        98     2.2       1,544
                                                  92.17
      86         86         86   BAYER PHARMA LTD.                23        5.86      0.14     -11.3        68.57   0.15     -0.4         68.57   0.15        -6      81     0.9        1498
                               * BAYER PHARMA LTD.                23        5.86      0.14     -11.3        68.57   0.15     -0.4         68.57   0.15        -6      81     0.9       1,498

      87         87         81     NATCO PHARMA                117          6.57      0.16       2.4        66.09   0.14         7        66.09   0.14     0.8        86     3.4        1447
                                 * NATCO PHARMA                117          6.57      0.16       2.4        66.09   0.14         7        66.09   0.14     0.8        86     3.4       1,447

      88         88         84     BRITISH BIOLOGICAL             17        6.04      0.15      19.9        66.03   0.14         26       66.03   0.14    18.8       102     0.2        1443
                                 * BRITISH BIOLOGICAL             17        6.04      0.15      19.9        66.03   0.14         26       66.03   0.14    18.8       102     0.2       1,443




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                    INDIA-SSA                                                                                   PAGE     8
                                                                                              DECEMBER 2010




                                                                                      MONTH                        CUMULATIVE                               12 MONTHS TO DATE
            RANKINGS                                            NO
                                          CORPORATIONS                    Values In                +        Values In            +        Values In              +                %         VALUES
12M         CUM         MON                                     PROD       Crores       %         -%         Crores     %       -%         Crores     %         -%        EVOL    N.P       $ +000
                                                      12M.%

      89          89          93      OZONE                          78        4.89      0.12      -6.4         60.40   0.13     10.8         60.40   0.13        4.5        90                1320
                                    + OZONE                          78        4.89      0.12      -6.4         60.40   0.13     10.8         60.40   0.13        4.5        90               1,320

      90          90          92      BHARAT SERUM                   44        5.02      0.12      -7.4         58.51   0.13      8.9         58.51   0.13        2.6        88     1.4        1279
                                    * BHARAT SERUM                   44        5.02      0.12      -7.4         58.51   0.13      8.9         58.51   0.13        2.6        88     1.4       1,279
                                                      92.85
      91          91          94      VERITAZ HEALTHCARE             87        4.77      0.12      11.8         55.38   0.12         33       55.38   0.12       25.8       108     4.4        1209
                                    * VERITAZ HEALTHCARE             87        4.77      0.12      11.8         55.38   0.12         33       55.38   0.12       25.8       108     4.4       1,209

      92          92          97      COMED CHEMICALS                93        4.38      0.11      -7.7         54.81   0.12         12       54.81   0.12        5.6        91                1197
                                    + COMED CHEMICALS                93        4.38      0.11      -7.7         54.81   0.12         12       54.81   0.12        5.6        91               1,197

      93          93          95      MAPRA LABS                     61        4.68      0.12       2.8         54.59   0.12      5.6         54.59   0.12       -0.6        85                1193
                                    + MAPRA LABS                     61        4.68      0.12       2.8         54.59   0.12      5.6         54.59   0.12       -0.6        85               1,193

      94          94          89      GALDERMA                       14        5.31      0.13      11.2         51.71   0.11     29.4         51.71   0.11       22.2       105                1130
                                    + GALDERMA                       14        5.31      0.13      11.2         51.71   0.11     29.4         51.71   0.11       22.2       105               1,130

      95          95          96      OVERSEAS                       63        4.40      0.11       4.5         51.52   0.11     54.8         51.52   0.11       46.7       126         3      1126
                                    * OVERSEAS                       63        4.40      0.11       4.5         51.52   0.11     54.8         51.52   0.11       46.7       126         3     1,126
                                                        93.42
      96          96          109     LABORATE PHARMA             140          3.48      0.09     -22.5         51.38   0.11      5.5         51.38   0.11       -0.5        85     3.1        1122
                                    * LABORATE PHARMA             140          3.48      0.09     -22.5         51.38   0.11      5.5         51.38   0.11       -0.5        85     3.1       1,122

      97          97          100     JENBURKT                       57        4.15         0.1        -9       51.35   0.11     14.8         51.35   0.11        8.4        93                1122
                                    + JENBURKT                       57        4.15         0.1        -9       51.35   0.11     14.8         51.35   0.11        8.4        93               1,122

      98          98          105     KHANDELWAL                  141          3.88         0.1   -17.7         51.27   0.11      2.2         51.27   0.11       -3.5        83     0.4        1120
                                    * KHANDELWAL                  141          3.88         0.1   -17.7         51.27   0.11      2.2         51.27   0.11       -3.5        83     0.4       1,120

      99          99          102     JUGGAT PHARMA                  33        3.97         0.1     7.6         50.88   0.11     17.5         50.88   0.11       10.8        95                1112
                                    + JUGGAT PHARMA                  33        3.97         0.1     7.6         50.88   0.11     17.5         50.88   0.11       10.8        95               1,112

      100         100         91      GRANDIX                     126          5.29      0.13      -1.3         50.70   0.11     -5.5         50.70   0.11      -10.8        77                1108
                                    + GRANDIX                     126          5.29      0.13      -1.3         50.70   0.11     -5.5         50.70   0.11      -10.8        77               1,108
                                                        93.97
      101         101         111     AGLOWMED                       60        3.42      0.08     -15.1         48.94    0.1      0.5         48.94       0.1    -5.1        81                1069
                                    + AGLOWMED                       60        3.42      0.08     -15.1         48.94    0.1      0.5         48.94       0.1    -5.1        81               1,069

      102         102         101     THEMIS MEDICARE                77        4.08         0.1    -3.1         48.07    0.1     18.6         48.07       0.1        12      96     0.2        1051
                                    * THEMIS MEDICARE                77        4.08         0.1    -3.1         48.07    0.1     18.6         48.07       0.1        12      96     0.2       1,051




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                   INDIA-SSA                                                                                 PAGE     9
                                                                                             DECEMBER 2010




                                                                                     MONTH                      CUMULATIVE                               12 MONTHS TO DATE
            RANKINGS                                          NO
                                          CORPORATIONS                   Values In                +      Values In            +        Values In              +                %         VALUES
12M         CUM         MON                                   PROD        Crores       %         -%       Crores     %       -%         Crores     %         -%        EVOL    N.P       $ +000
                                                   12M.%
      103         103         107     DWD PHARMACEUTICAL           72         3.76      0.09       -13       47.27    0.1      3.4         47.27       0.1    -2.3        84     2.9        1032
                                    * DWD PHARMACEUTICAL           72         3.76      0.09       -13       47.27    0.1      3.4         47.27       0.1    -2.3        84     2.9       1,032

      104         104         120     CLARIS LIFESCIENCE           66         2.89      0.07       4.4       46.88    0.1         16       46.88       0.1     9.4        94     0.5        1024
                                    * CLARIS LIFESCIENCE           66         2.89      0.07       4.4       46.88    0.1         16       46.88       0.1     9.4        94     0.5       1,024

      105         105         85   ERIS LIFE SCIENCES              55         6.01      0.15       165       46.64    0.1     301          46.64       0.1   285.4       331    12.1        1020
                                 * ERIS LIFE SCIENCES              55         6.01      0.15       165       46.64    0.1     301          46.64       0.1   285.4       331    12.1       1,020
                                                    94.48
      106         106         99   ALCON                           15         4.21         0.1    29.7       45.91    0.1     45.3         45.91       0.1    37.1       118                1003
                                 + ALCON                           15         4.21         0.1    29.7       45.91    0.1     45.3         45.91       0.1    37.1       118               1,003

      107         107         104     ICPA HEALTH                  24         3.91         0.1     0.6       45.88    0.1     16.9         45.88       0.1    10.3        95                1003
                                      ICPA HEALTH                  24         3.91         0.1     0.6       45.88    0.1     16.9         45.88       0.1    10.3        95               1,003

      108         108         98      ZANDU PHARMA              135           4.34      0.11     -10.6       45.37    0.1         -4       45.37       0.1    -9.3        78                 991
                                      ZANDU PHARMA              135           4.34      0.11     -10.6       45.37    0.1         -4       45.37       0.1    -9.3        78                 991

      109         109         119     HEINZ                          5        2.90      0.07       9.2       44.59    0.1     21.3         44.59       0.1    13.8        98                 975
                                      HEINZ                          5        2.90      0.07       9.2       44.59    0.1     21.3         44.59       0.1    13.8        98                 975

      110         110         110     TORQUE PHARMA                93         3.48      0.09     -27.2       43.40   0.09      8.6         43.40   0.09        2.6        88     0.3         949
                                    * TORQUE PHARMA                93         3.48      0.09     -27.2       43.40   0.09      8.6         43.40   0.09        2.6        88     0.3         949
                                                      94.96
      111         111         103     UNISON PHARMA                41         3.91         0.1    25.9       41.56   0.09     47.3         41.56   0.09       39.2       120     0.2         908
                                    * UNISON PHARMA                41         3.91         0.1    25.9       41.56   0.09     47.3         41.56   0.09       39.2       120     0.2         908

      112         112         108     NEON LABS                    77         3.49      0.09      -2.1       41.22   0.09     30.5         41.22   0.09       23.4       106     0.4         900
                                    * NEON LABS                    77         3.49      0.09      -2.1       41.22   0.09     30.5         41.22   0.09       23.4       106     0.4         900

      113         113         114     UNIMARCK PHARMA              89         3.33      0.08      -4.2       39.67   0.08     18.8         39.67   0.08           12      96         1       867
                                    * UNIMARCK PHARMA              89         3.33      0.08      -4.2       39.67   0.08     18.8         39.67   0.08           12      96         1       867

      114         114         113     AIMIL                        23         3.41      0.08       5.3       39.43   0.08     27.6         39.43   0.08       20.4       103                 862
                                      AIMIL                        23         3.41      0.08       5.3       39.43   0.08     27.6         39.43   0.08       20.4       103                 862

      115         115         106     PALSON DRUG                  75         3.76      0.09      11.7       38.81   0.08     19.8         38.81   0.08       13.1        97     1.4         848
                                    * PALSON DRUG                  75         3.76      0.09      11.7       38.81   0.08     19.8         38.81   0.08       13.1        97     1.4         848
                                                      95.39
      116         116         122     UNI SANKYO                   49         2.83      0.07       7.5       38.53   0.08     31.2         38.53   0.08       23.6       106     0.4         841
                                    * UNI SANKYO                   49         2.83      0.07       7.5       38.53   0.08     31.2         38.53   0.08       23.6       106     0.4         841

      117         117         112     PSYCHOTROPICS             202           3.41      0.08       5.2       37.33   0.08     10.4         37.33   0.08           4       89     0.8         816




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                      INDIA-SSA                                                                              PAGE    10
                                                                                                DECEMBER 2010




                                                                                        MONTH                       CUMULATIVE                             12 MONTHS TO DATE
            RANKINGS                                             NO
                                          CORPORATIONS                      Values In               +        Values In            +        Values In           +               %         VALUES
12M         CUM         MON                                      PROD        Crores       %        -%         Crores     %       -%         Crores     %      -%       EVOL    N.P       $ +000
                                                       12M.%
                                    * PSYCHOTROPICS                202           3.41      0.08       5.2        37.33   0.08     10.4         37.33   0.08        4      89     0.8            816

      118         118         115     ORDAIN HEALTHCARE               73         3.19      0.08      12.1        36.06   0.08     41.2         36.06   0.08    33.4      114     2.4            788
                                    * ORDAIN HEALTHCARE               73         3.19      0.08      12.1        36.06   0.08     41.2         36.06   0.08    33.4      114     2.4            788

      119         119         121     SHINE PHARMA                    92         2.89      0.07       5.1        35.26   0.08         30       35.26   0.08    22.7      105     0.2            770
                                    * SHINE PHARMA                    92         2.89      0.07       5.1        35.26   0.08         30       35.26   0.08    22.7      105     0.2            770

      120         120         117     INDI PHARMA                     35         2.96      0.07       1.1        34.38   0.07     10.3         34.38   0.07     4.3       89         0          751
                                    * INDI PHARMA                     35         2.96      0.07       1.1        34.38   0.07     10.3         34.38   0.07     4.3       89         0          751
                                                         95.78
      121         121         116     GROUP                           54         3.09      0.08         4        34.33   0.07     18.1         34.33   0.07    11.5       96     0.2            750
                                    * GROUP                           54         3.09      0.08         4        34.33   0.07     18.1         34.33   0.07    11.5       96     0.2            750

      122         122         118     OBSURGE BIOTECH                 69         2.96      0.07      10.2        34.09   0.07     10.5         34.09   0.07        4      89     4.6            745
                                    * OBSURGE BIOTECH                 69         2.96      0.07      10.2        34.09   0.07     10.5         34.09   0.07        4      89     4.6            745

      123         123         124     RELIANCE                     101           2.73      0.07         49       31.51   0.07    130.6         31.51   0.07   119.3      188     4.3            689
                                    * RELIANCE                     101           2.73      0.07         49       31.51   0.07    130.6         31.51   0.07   119.3      188     4.3            689

      124         124         136     RECKITT BENCKISER               12         2.26      0.06     -11.7        31.19   0.07     -7.1         31.19   0.07    -12.5      75                    681
                                      RECKITT BENCKISER               12         2.26      0.06     -11.7        31.19   0.07     -7.1         31.19   0.07    -12.5      75                    681

      125         125         126     GALPHA LABS                     96         2.67      0.07      10.7        30.86   0.07     14.5         30.86   0.07        8      93     0.9            675
                                    * GALPHA LABS                     96         2.67      0.07      10.7        30.86   0.07     14.5         30.86   0.07        8      93     0.9            675
                                                         96.12
      126         126         127     LUNDBECK                          6        2.65      0.07       9.2        30.59   0.07      9.7         30.59   0.07     3.3       89                    669
                                    + LUNDBECK                          6        2.65      0.07       9.2        30.59   0.07      9.7         30.59   0.07     3.3       89                    669

      127         127         123     TALENT                          92         2.79      0.07      10.1        30.25   0.06         15       30.25   0.06     8.3       93         4          661
                                    * TALENT                          92         2.79      0.07      10.1        30.25   0.06         15       30.25   0.06     8.3       93         4          661

      128         128         125     SHALAKS PHARMA               100           2.67      0.07         3        30.21   0.06      9.9         30.21   0.06     3.5       89     1.8            660
                                    * SHALAKS PHARMA               100           2.67      0.07         3        30.21   0.06      9.9         30.21   0.06     3.5       89     1.8            660

      129         129         131     CONCEPT PHARMA                  95         2.41      0.06      -5.9        29.73   0.06     16.6         29.73   0.06    10.2       95     0.1            649
                                    * CONCEPT PHARMA                  95         2.41      0.06      -5.9        29.73   0.06     16.6         29.73   0.06    10.2       95     0.1            649

      130         130         134     VHB LIFESCIENCES             100           2.35      0.06     -16.9        29.59   0.06     13.7         29.59   0.06     7.4       92     1.2            646
                                    * VHB LIFESCIENCES             100           2.35      0.06     -16.9        29.59   0.06     13.7         29.59   0.06     7.4       92     1.2            646
                                                         96.45
      131         131         139     ELAN PHARMA                     32         2.19      0.05      -3.6        28.32   0.06     18.3         28.32   0.06    11.7       96     0.6            619
                                    * ELAN PHARMA                     32         2.19      0.05      -3.6        28.32   0.06     18.3         28.32   0.06    11.7       96     0.6            619




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                    INDIA-SSA                                                                            PAGE    11
                                                                                              DECEMBER 2010




                                                                                      MONTH                      CUMULATIVE                             12 MONTHS TO DATE
            RANKINGS                                           NO
                                          CORPORATIONS                    Values In               +       Values In            +        Values In           +                %       VALUES
12M         CUM         MON                                    PROD        Crores       %        -%        Crores     %       -%         Crores     %      -%        EVOL    N.P     $ +000
                                                       12M.%

      132         132         135     SUNWAYS                       88         2.33      0.06      -9.2       27.65   0.06     11.2         27.65   0.06     4.8        90     2.7          604
                                    * SUNWAYS                       88         2.33      0.06      -9.2       27.65   0.06     11.2         27.65   0.06     4.8        90     2.7          604

      133         133         140     KARNATAKA ANTIBIOT            62         2.14      0.05      -3.8       27.61   0.06     31.4         27.61   0.06    24.2       107                  603
                                    + KARNATAKA ANTIBIOT            62         2.14      0.05      -3.8       27.61   0.06     31.4         27.61   0.06    24.2       107                  603

      134         134         133     YASH PHARMA                   65         2.40      0.06       4.8       27.56   0.06         32       27.56   0.06    24.8       107                  602
                                    + YASH PHARMA                   65         2.40      0.06       4.8       27.56   0.06         32       27.56   0.06    24.8       107                  602

      135         135         143     LINCOLN PHARMA             198           2.02      0.05      -8.3       27.32   0.06     12.2         27.32   0.06        6       91     4.8          597
                                    * LINCOLN PHARMA             198           2.02      0.05      -8.3       27.32   0.06     12.2         27.32   0.06        6       91     4.8          597
                                                       96.74
      136         136         129     MOLEKULE INDIA                52         2.47      0.06      14.5       26.96   0.06     54.5         26.96   0.06    46.5       126     0.8          589
                                    * MOLEKULE INDIA                52         2.47      0.06      14.5       26.96   0.06     54.5         26.96   0.06    46.5       126     0.8          589

      137         137         132     WINGS PHARMA                  47         2.40      0.06      21.9       26.84   0.06     29.8         26.84   0.06    22.5       105                  587
                                      WINGS PHARMA                  47         2.40      0.06      21.9       26.84   0.06     29.8         26.84   0.06    22.5       105                  587

      138         138         130     STRESSENBURG                  17         2.42      0.06      24.9       26.21   0.06     25.1         26.21   0.06    18.2       101     0.8          573
                                    * STRESSENBURG                  17         2.42      0.06      24.9       26.21   0.06     25.1         26.21   0.06    18.2       101     0.8          573

      139         139         142     BAXTER                        20         2.07      0.05      -4.4       25.69   0.05     -8.3         25.69   0.05    -13.7       74                  561
                                    + BAXTER                        20         2.07      0.05      -4.4       25.69   0.05     -8.3         25.69   0.05    -13.7       74                  561

      140         140         141     BENNET PHARMA                 21         2.09      0.05      15.8       25.65   0.05     27.9         25.65   0.05    20.7       104                  561
                                    + BENNET PHARMA                 21         2.09      0.05      15.8       25.65   0.05     27.9         25.65   0.05    20.7       104                  561
                                                       97.02
      141         141         137     EISAI PHARMA                    8        2.25      0.06      14.3       25.16   0.05     26.9         25.16   0.05    19.8       103     7.5          550
                                    * EISAI PHARMA                    8        2.25      0.06      14.3       25.16   0.05     26.9         25.16   0.05    19.8       103     7.5          550

      142         142         147     PARENTERAL DRUGS              84         1.87      0.05      -6.5       25.15   0.05     13.2         25.15   0.05     6.8        92     0.7          549
                                    * PARENTERAL DRUGS              84         1.87      0.05      -6.5       25.15   0.05     13.2         25.15   0.05     6.8        92     0.7          549

      143         143         128     SAMARTH PHARMA                80         2.63      0.06      57.6       24.35   0.05     73.3         24.35   0.05    63.7       141     2.3          532
                                    * SAMARTH PHARMA                80         2.63      0.06      57.6       24.35   0.05     73.3         24.35   0.05    63.7       141     2.3          532

      144         144         146     MEDO PHARMA                   49         1.91      0.05       2.9       22.60   0.05     36.4         22.60   0.05    29.3       111                  493
                                    + MEDO PHARMA                   49         1.91      0.05       2.9       22.60   0.05     36.4         22.60   0.05    29.3       111                  493

      145         145         155     SEAGULL LABS               211           1.59      0.04     -35.5       22.34   0.05     23.4         22.34   0.05        17     100     5.9          488
                                    * SEAGULL LABS               211           1.59      0.04     -35.5       22.34   0.05     23.4         22.34   0.05        17     100     5.9          488
                                                       97.28




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                    INDIA-SSA                                                                              PAGE    12
                                                                                              DECEMBER 2010




                                                                                      MONTH                      CUMULATIVE                             12 MONTHS TO DATE
            RANKINGS                                            NO
                                          CORPORATIONS                    Values In               +       Values In            +        Values In           +                %         VALUES
12M         CUM         MON                                     PROD       Crores       %        -%        Crores     %       -%         Crores     %      -%        EVOL    N.P       $ +000
                                                       12M.%
      146         146         145     HELIOS                         88        1.96      0.05      12.2       20.81   0.04         36       20.81   0.04    28.6       110     3.1            454
                                    * HELIOS                         88        1.96      0.05      12.2       20.81   0.04         36       20.81   0.04    28.6       110     3.1            454

      147         147         150     MOREPEN LABS                   97        1.82      0.04      -0.2       20.55   0.04     13.9         20.55   0.04     7.6        92     1.5            449
                                    * MOREPEN LABS                   97        1.82      0.04      -0.2       20.55   0.04     13.9         20.55   0.04     7.6        92     1.5            449

      148         148         138     AMRUTANJAN                     10        2.19      0.05      -4.9       20.54   0.04     -6.3         20.54   0.04    -11.6       76                    449
                                      AMRUTANJAN                     10        2.19      0.05      -4.9       20.54   0.04     -6.3         20.54   0.04    -11.6       76                    449

      149         149         158     STADMED PRIVATE                49        1.49      0.04       6.8       20.08   0.04     14.3         20.08   0.04     7.9        93                    439
                                    + STADMED PRIVATE                49        1.49      0.04       6.8       20.08   0.04     14.3         20.08   0.04     7.9        93                    439

      150         150         148     LEBEN LABS                     41        1.86      0.05      59.2       19.69   0.04     37.3         19.69   0.04    29.8       111                    430
                                      LEBEN LABS                     41        1.86      0.05      59.2       19.69   0.04     37.3         19.69   0.04    29.8       111                    430
                                                        97.49
      151         151         149     SH PHARMA                      31        1.83      0.04      -4.3       19.64   0.04     12.1         19.64   0.04        6       91         5          429
                                    * SH PHARMA                      31        1.83      0.04      -4.3       19.64   0.04     12.1         19.64   0.04        6       91         5          429

      152         152         165     ESKAG PHARMA                   24        1.34      0.03     -23.3       19.38   0.04     20.9         19.38   0.04    14.3        98                    423
                                    + ESKAG PHARMA                   24        1.34      0.03     -23.3       19.38   0.04     20.9         19.38   0.04    14.3        98                    423

      153         153         159     FRESENIUS KABI                 27        1.47      0.04         7       19.13   0.04      1.1         19.13   0.04     -4.8       82     0.3            418
                                    * FRESENIUS KABI                 27        1.47      0.04         7       19.13   0.04      1.1         19.13   0.04     -4.8       82     0.3            418

      154         154         156     VANGUARD                       35        1.56      0.04      -2.5       18.60   0.04      4.9         18.60   0.04     -0.9       85                    406
                                      VANGUARD                       35        1.56      0.04      -2.5       18.60   0.04      4.9         18.60   0.04     -0.9       85                    406

      155         155         153     GUFIC                          63        1.72      0.04      36.3       18.54   0.04     32.2         18.54   0.04    24.6       107     3.1            405
                                    * GUFIC                          63        1.72      0.04      36.3       18.54   0.04     32.2         18.54   0.04    24.6       107     3.1            405
                                                         97.7
      156         156         152     NOEL PHARMA                    91        1.77      0.04      30.7       18.40   0.04     19.7         18.40   0.04        13      97     2.9            402
                                    * NOEL PHARMA                    91        1.77      0.04      30.7       18.40   0.04     19.7         18.40   0.04        13      97     2.9            402

      157         157         166     MERCURY LABS                   41        1.29      0.03     -12.3       17.55   0.04     17.8         17.55   0.04    11.1        95     0.1            383
                                    * MERCURY LABS                   41        1.29      0.03     -12.3       17.55   0.04     17.8         17.55   0.04    11.1        95     0.1            383

      158         158         154     A.N.PHARMACIA                  34        1.70      0.04      55.8       17.30   0.04     37.2         17.30   0.04    28.9       111     0.7            378
                                    * A.N.PHARMACIA                  34        1.70      0.04      55.8       17.30   0.04     37.2         17.30   0.04    28.9       111     0.7            378

      159         159         164     ADONIS                         18        1.37      0.03     -14.1       17.25   0.04     14.8         17.25   0.04     8.7        93                    377
                                      ADONIS                         18        1.37      0.03     -14.1       17.25   0.04     14.8         17.25   0.04     8.7        93                    377

      160         160         161     JAWA                           48        1.46      0.04       4.5       17.20   0.04     18.9         17.20   0.04        12      96     1.8            376




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                    INDIA-SSA                                                                            PAGE    13
                                                                                              DECEMBER 2010




                                                                                      MONTH                      CUMULATIVE                           12 MONTHS TO DATE
            RANKINGS                                            NO
                                            CORPORATIONS                  Values In               +       Values In            +      Values In           +                %         VALUES
12M         CUM         MON                                     PROD       Crores       %        -%        Crores     %       -%       Crores     %      -%        EVOL    N.P       $ +000
                                                      12M.%
                                    * JAWA                           48        1.46      0.04       4.5       17.20   0.04     18.9       17.20   0.04        12      96     1.8            376
                                                        97.89
      161         161         151     BAN LABS.                      36        1.78      0.04      14.2       16.97   0.04     43.9       16.97   0.04    36.2       117                    371
                                      BAN LABS.                      36        1.78      0.04      14.2       16.97   0.04     43.9       16.97   0.04    36.2       117                    371

      162         162         157     GLAND PHARMA                   30        1.50      0.04      32.1       16.54   0.04     37.8       16.54   0.04    30.1       112     4.4            361
                                    * GLAND PHARMA                   30        1.50      0.04      32.1       16.54   0.04     37.8       16.54   0.04    30.1       112     4.4            361

      163         163         163     SYNCOM                      111          1.37      0.03     -10.5       15.63   0.03      9.2       15.63   0.03     3.3        89                    341
                                    + SYNCOM                      111          1.37      0.03     -10.5       15.63   0.03      9.2       15.63   0.03     3.3        89                    341

      164         164         162     FEM CARE PHARMA                42        1.38      0.03       0.1       15.36   0.03      1.9       15.36   0.03     -3.9       83     1.4            336
                                    * FEM CARE PHARMA                42        1.38      0.03       0.1       15.36   0.03      1.9       15.36   0.03     -3.9       83     1.4            336

      165         165         171     KEE PHARMA                     35        1.14      0.03     -19.1       15.08   0.03      0.8       15.08   0.03     -4.9       82                    329
                                      KEE PHARMA                     35        1.14      0.03     -19.1       15.08   0.03      0.8       15.08   0.03     -4.9       82                    329
                                                        98.06
      166         166         167     ALARSIN                        14        1.26      0.03       3.5       14.71   0.03     12.1       14.71   0.03     5.6        91                    321
                                      ALARSIN                        14        1.26      0.03       3.5       14.71   0.03     12.1       14.71   0.03     5.6        91                    321

      167         167         177     KLAR SEHEN                     46        1.03      0.03      -0.2       14.65   0.03     20.9       14.65   0.03    13.9        98                    320
                                      KLAR SEHEN                     46        1.03      0.03      -0.2       14.65   0.03     20.9       14.65   0.03    13.9        98                    320

      168         168         160     KON TEST CHEMICALS             36        1.47      0.04      43.7       14.07   0.03     -4.2       14.07   0.03     -9.8       77                    307
                                      KON TEST CHEMICALS             36        1.47      0.04      43.7       14.07   0.03     -4.2       14.07   0.03     -9.8       77                    307

      169         169         173     ACRON                          31        1.13      0.03      -6.5       14.05   0.03      5.3       14.05   0.03     -1.3       85         0          307
                                    * ACRON                          31        1.13      0.03      -6.5       14.05   0.03      5.3       14.05   0.03     -1.3       85         0          307

      170         170         170     STEDMAN                        49        1.16      0.03         1       13.25   0.03     16.8       13.25   0.03    10.4        95    21.2            289
                                    * STEDMAN                        49        1.16      0.03         1       13.25   0.03     16.8       13.25   0.03    10.4        95    21.2            289
                                                        98.21
      171         171         187     FLAMINGO PHARMA                23        0.93      0.02     -21.5       13.23   0.03      8.5       13.23   0.03     2.4        88         3          289
                                    * FLAMINGO PHARMA                23        0.93      0.02     -21.5       13.23   0.03      8.5       13.23   0.03     2.4        88         3          289

      172         172         168     MPI                            20        1.25      0.03      13.2       13.21   0.03     21.6       13.21   0.03    14.6        98                    289
                                      MPI                            20        1.25      0.03      13.2       13.21   0.03     21.6       13.21   0.03    14.6        98                    289

      173         173         179     MENARINI RAUNAQ                17        1.00      0.02       0.5       13.19   0.03     41.6       13.19   0.03    33.9       115                    288
                                    + MENARINI RAUNAQ                17        1.00      0.02       0.5       13.19   0.03     41.6       13.19   0.03    33.9       115                    288

      174         174         183     GUJARAT TERCE                  78        0.97      0.02       -35       13.03   0.03     -5.3       13.03   0.03    -10.7       77                    285
                                      GUJARAT TERCE                  78        0.97      0.02       -35       13.03   0.03     -5.3       13.03   0.03    -10.7       77                    285




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                    INDIA-SSA                                                                           PAGE    14
                                                                                              DECEMBER 2010




                                                                                      MONTH                       CUMULATIVE                           12 MONTHS TO DATE
            RANKINGS                                            NO
                                          CORPORATIONS                    Values In               +        Values In            +      Values In           +                %       VALUES
12M         CUM         MON                                     PROD       Crores       %        -%         Crores     %       -%       Crores     %      -%        EVOL    N.P     $ +000
                                                       12M.%

      175         175         176   PHARMA-TECH INDIA                39        1.04      0.03       9.4        13.00   0.03     32.4       13.00   0.03    24.7       107                  284
                                    PHARMA-TECH INDIA                39        1.04      0.03       9.4        13.00   0.03     32.4       13.00   0.03    24.7       107                  284
                                                    98.35
      176         176         180   ENTOD                            62        0.99      0.02       2.3        12.78   0.03     33.1       12.78   0.03    25.7       108     0.9          279
                                  * ENTOD                            62        0.99      0.02       2.3        12.78   0.03     33.1       12.78   0.03    25.7       108     0.9          279

      177         177         169     MERIDIAN LAB                   51        1.25      0.03      31.7        12.60   0.03     35.1       12.60   0.03    27.4       109     0.1          275
                                    * MERIDIAN LAB                   51        1.25      0.03      31.7        12.60   0.03     35.1       12.60   0.03    27.4       109     0.1          275

      178         178         172     FERRING PHARMA                 19        1.13      0.03       4.2        12.59   0.03     22.4       12.59   0.03    15.5        99                  275
                                      FERRING PHARMA                 19        1.13      0.03       4.2        12.59   0.03     22.4       12.59   0.03    15.5        99                  275

      179         179         178     SKYMAX LABS                    24        1.01      0.02      25.2        12.31   0.03    -12.5       12.31   0.03    -17.5       71    18.2          269
                                    * SKYMAX LABS                    24        1.01      0.02      25.2        12.31   0.03    -12.5       12.31   0.03    -17.5       71    18.2          269

      180         180         175     NULIFE                         36        1.04      0.03      -0.5        11.86   0.03      9.2       11.86   0.03        3       88                  259
                                    + NULIFE                         36        1.04      0.03      -0.5        11.86   0.03      9.2       11.86   0.03        3       88                  259
                                                       98.48
      181         181         191     LEO PHARMA                     39        0.87      0.02      28.6        11.79   0.03     30.8       11.79   0.03    23.7       106                  258
                                      LEO PHARMA                     39        0.87      0.02      28.6        11.79   0.03     30.8       11.79   0.03    23.7       106                  258

      182         182         199     THEMIS PHARMA                  14        0.79      0.02     -27.9        11.59   0.02      2.7       11.59   0.02        -3      83                  253
                                    + THEMIS PHARMA                  14        0.79      0.02     -27.9        11.59   0.02      2.7       11.59   0.02        -3      83                  253

      183         183         181     INGA                           38        0.98      0.02      -1.9        11.07   0.02     13.7       11.07   0.02     7.3        92     0.4          242
                                    * INGA                           38        0.98      0.02      -1.9        11.07   0.02     13.7       11.07   0.02     7.3        92     0.4          242

      184         184         182     AR EX                          25        0.97      0.02         -3       11.04   0.02     15.6       11.04   0.02     9.1        94     5.3          241
                                    * AR EX                          25        0.97      0.02         -3       11.04   0.02     15.6       11.04   0.02     9.1        94     5.3          241

      185         185         189     JUPITER                        29        0.89      0.02       9.2        11.00   0.02     17.7       11.00   0.02    11.1        95     0.9          240
                                    * JUPITER                        29        0.89      0.02       9.2        11.00   0.02     17.7       11.00   0.02    11.1        95     0.9          240
                                                         98.6
      186         186         185     PULSE PHARMA                   43        0.96      0.02       1.5        10.97   0.02     11.9       10.97   0.02     5.4        90                  240
                                    + PULSE PHARMA                   43        0.96      0.02       1.5        10.97   0.02     11.9       10.97   0.02     5.4        90                  240

      187         187         174     OPTHO REMEDIES                 52        1.08      0.03      40.3        10.89   0.02     19.6       10.89   0.02    12.5        97                  238
                                    + OPTHO REMEDIES                 52        1.08      0.03      40.3        10.89   0.02     19.6       10.89   0.02    12.5        97                  238

      188         188         195     LI TAKA PHARMA                 42        0.84      0.02       3.7        10.72   0.02     -4.6       10.72   0.02     -10        77                  234
                                      LI TAKA PHARMA                 42        0.84      0.02       3.7        10.72   0.02     -4.6       10.72   0.02     -10        77                  234




IMS, ALL RIGHTS RESERVED
LEADING CORPORATION BY VALUE                                                                     INDIA-SSA                                                                           PAGE    15
                                                                                               DECEMBER 2010




                                                                                       MONTH                      CUMULATIVE                             12 MONTHS TO DATE
            RANKINGS                                            NO
                                            CORPORATIONS                   Values In               +       Values In            +        Values In           +               %       VALUES
12M         CUM         MON                                     PROD        Crores       %        -%        Crores     %       -%         Crores     %      -%       EVOL    N.P     $ +000
                                                        12M.%
      189         189         184     UNI LABS                       12         0.96      0.02      -1.6       10.66   0.02     12.6         10.66   0.02     6.2       91                  233
                                      UNI LABS                       12         0.96      0.02      -1.6       10.66   0.02     12.6         10.66   0.02     6.2       91                  233

      190         190         193     LA PHARMA                      56         0.86      0.02      -6.5       10.32   0.02     25.3         10.32   0.02    18.5      102                  226
                                    + LA PHARMA                      56         0.86      0.02      -6.5       10.32   0.02     25.3         10.32   0.02    18.5      102                  226
                                                        98.72
      191         191         200     REKVINA                        41         0.78      0.02     -11.6       10.14   0.02      9.2         10.14   0.02        3      88     1.6          221
                                    * REKVINA                        41         0.78      0.02     -11.6       10.14   0.02      9.2         10.14   0.02        3      88     1.6          221

      192         192         190     BDF                            13         0.87      0.02     -21.1       10.07   0.02     -6.4         10.07   0.02    -11.6      76                  220
                                      BDF                            13         0.87      0.02     -21.1       10.07   0.02     -6.4         10.07   0.02    -11.6      76                  220

      193         193         212     HINDUSTAN ANTIBIOT             31         0.64      0.02     -17.6        9.90   0.02     23.5          9.90   0.02    16.6      100                  216
                                      HINDUSTAN ANTIBIOT             31         0.64      0.02     -17.6        9.90   0.02     23.5          9.90   0.02    16.6      100                  216

      194         194         192     STERKEM                        42         0.86      0.02      22.6        9.85   0.02     59.8          9.85   0.02    51.1      130                  215
                                      STERKEM                        42         0.86      0.02      22.6        9.85   0.02     59.8          9.85   0.02    51.1      130                  215

      195         195         202     MARTIN HARRIS                    5        0.75      0.02      -8.8        9.76   0.02     18.6          9.76   0.02    11.9       96                  213
                                      MARTIN HARRIS                    5        0.75      0.02      -8.8        9.76   0.02     18.6          9.76   0.02    11.9       96                  213
                                                        98.82
      196         196         194     RESILIENT COSME                30         0.85      0.02       5.1        9.74   0.02     12.5          9.74   0.02     5.9       91     4.8          213
                                    * RESILIENT COSME                30         0.85      0.02       5.1        9.74   0.02     12.5          9.74   0.02     5.9       91     4.8          213

      197         197         196     TWILIGHT MARCANTIL             38         0.82      0.02      -3.6        9.73   0.02     -4.3          9.73   0.02     -9.6      78     4.5          212
                                    * TWILIGHT MARCANTIL             38         0.82      0.02      -3.6        9.73   0.02     -4.3          9.73   0.02     -9.6      78     4.5          212

      198         198         211     TIDAL LABS                     32         0.64      0.02     -33.1        9.57   0.02     -7.4          9.57   0.02    -12.6      75                  209
                                    + TIDAL LABS                     32         0.64      0.02     -33.1        9.57   0.02     -7.4          9.57   0.02    -12.6      75                  209

      199         199         204     EISEN PHARMA                   19         0.74      0.02      -7.4        9.39   0.02         19        9.39   0.02    12.3       96                  205
                                      EISEN PHARMA                   19         0.74      0.02      -7.4        9.39   0.02         19        9.39   0.02    12.3       96                  205

      200         200         216     LARK LABS                   102           0.63      0.02     -37.2        9.24   0.02    -19.3          9.24   0.02    -24.1      65                  202
                                      LARK LABS                   102           0.63      0.02     -37.2        9.24   0.02    -19.3          9.24   0.02    -24.1      65                  202
                                                        98.92
      201         201         206     NAVIL                          36         0.70      0.02      -8.3        9.20   0.02     14.2          9.20   0.02     8.1       93                  201
                                    + NAVIL                          36         0.70      0.02      -8.3        9.20   0.02     14.2          9.20   0.02     8.1       93                  201

      202         202         186     STIEFEL                        23         0.93      0.02     721.1        8.97   0.02     18.5          8.97   0.02    10.7       95                  196
                                      STIEFEL                        23         0.93      0.02     721.1        8.97   0.02     18.5          8.97   0.02    10.7       95                  196

      203         203         207     OZONE AYURVEDICS                 8        0.68      0.02     -36.9        8.87   0.02         -9        8.87   0.02    -14.1      74                  194




IMS, ALL RIGHTS RESERVED
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010
Corporates 2010

More Related Content

What's hot

Angel Top Picks - July 16,2010
Angel Top Picks - July 16,2010Angel Top Picks - July 16,2010
Angel Top Picks - July 16,2010Angel Broking
 
MPOrtigas_samplecompFlat_ValidMarOnly
MPOrtigas_samplecompFlat_ValidMarOnlyMPOrtigas_samplecompFlat_ValidMarOnly
MPOrtigas_samplecompFlat_ValidMarOnlyBernadette Kitching
 
Impacto de solucion financiera propuesta por accionistas del Banco Nuevo Mundo
Impacto de solucion financiera propuesta por accionistas del Banco Nuevo MundoImpacto de solucion financiera propuesta por accionistas del Banco Nuevo Mundo
Impacto de solucion financiera propuesta por accionistas del Banco Nuevo Mundogonzaloromani
 
[ETHCon Korea 2019] Ahn sangsun 안상선
[ETHCon Korea 2019] Ahn sangsun 안상선[ETHCon Korea 2019] Ahn sangsun 안상선
[ETHCon Korea 2019] Ahn sangsun 안상선ethconkr
 
Equity tips and newsletter 18 Feb 2013
Equity tips and newsletter 18 Feb 2013Equity tips and newsletter 18 Feb 2013
Equity tips and newsletter 18 Feb 2013TheEquicom Advisory
 
【北海道教育大学】平成19年度環境報告書
【北海道教育大学】平成19年度環境報告書【北海道教育大学】平成19年度環境報告書
【北海道教育大学】平成19年度環境報告書env76
 
conoco phillips 2008Fourth Quarter
conoco phillips 2008Fourth Quarterconoco phillips 2008Fourth Quarter
conoco phillips 2008Fourth Quarterfinance1
 
Simulacion credito
Simulacion creditoSimulacion credito
Simulacion creditozimrri
 

What's hot (14)

Angel Top Picks - July 16,2010
Angel Top Picks - July 16,2010Angel Top Picks - July 16,2010
Angel Top Picks - July 16,2010
 
MPOrtigas_samplecompFlat_ValidMarOnly
MPOrtigas_samplecompFlat_ValidMarOnlyMPOrtigas_samplecompFlat_ValidMarOnly
MPOrtigas_samplecompFlat_ValidMarOnly
 
Total de notas
Total de notasTotal de notas
Total de notas
 
Impacto de solucion financiera propuesta por accionistas del Banco Nuevo Mundo
Impacto de solucion financiera propuesta por accionistas del Banco Nuevo MundoImpacto de solucion financiera propuesta por accionistas del Banco Nuevo Mundo
Impacto de solucion financiera propuesta por accionistas del Banco Nuevo Mundo
 
[ETHCon Korea 2019] Ahn sangsun 안상선
[ETHCon Korea 2019] Ahn sangsun 안상선[ETHCon Korea 2019] Ahn sangsun 안상선
[ETHCon Korea 2019] Ahn sangsun 안상선
 
Sample Budget
Sample BudgetSample Budget
Sample Budget
 
Angel Top Picks
Angel Top PicksAngel Top Picks
Angel Top Picks
 
Meta 28 03 2011
Meta 28 03 2011Meta 28 03 2011
Meta 28 03 2011
 
Equity tips and newsletter 18 Feb 2013
Equity tips and newsletter 18 Feb 2013Equity tips and newsletter 18 Feb 2013
Equity tips and newsletter 18 Feb 2013
 
Angel Top Picks
Angel Top PicksAngel Top Picks
Angel Top Picks
 
【北海道教育大学】平成19年度環境報告書
【北海道教育大学】平成19年度環境報告書【北海道教育大学】平成19年度環境報告書
【北海道教育大学】平成19年度環境報告書
 
Tabla f05
Tabla f05Tabla f05
Tabla f05
 
conoco phillips 2008Fourth Quarter
conoco phillips 2008Fourth Quarterconoco phillips 2008Fourth Quarter
conoco phillips 2008Fourth Quarter
 
Simulacion credito
Simulacion creditoSimulacion credito
Simulacion credito
 

Viewers also liked

Tabel Kesesuaian KBLI 2009 KBLI 2005
Tabel Kesesuaian KBLI 2009 KBLI 2005Tabel Kesesuaian KBLI 2009 KBLI 2005
Tabel Kesesuaian KBLI 2009 KBLI 2005Kacung Abdullah
 
Perceptual mapping techniques
Perceptual mapping techniquesPerceptual mapping techniques
Perceptual mapping techniquesAxay Pithava
 
Hype vs. Reality: The AI Explainer
Hype vs. Reality: The AI ExplainerHype vs. Reality: The AI Explainer
Hype vs. Reality: The AI ExplainerLuminary Labs
 
Study: The Future of VR, AR and Self-Driving Cars
Study: The Future of VR, AR and Self-Driving CarsStudy: The Future of VR, AR and Self-Driving Cars
Study: The Future of VR, AR and Self-Driving CarsLinkedIn
 

Viewers also liked (7)

Friends
FriendsFriends
Friends
 
Brands ims 2010
Brands ims 2010Brands ims 2010
Brands ims 2010
 
Tabel Kesesuaian KBLI 2009 KBLI 2005
Tabel Kesesuaian KBLI 2009 KBLI 2005Tabel Kesesuaian KBLI 2009 KBLI 2005
Tabel Kesesuaian KBLI 2009 KBLI 2005
 
Demand forecast
Demand forecastDemand forecast
Demand forecast
 
Perceptual mapping techniques
Perceptual mapping techniquesPerceptual mapping techniques
Perceptual mapping techniques
 
Hype vs. Reality: The AI Explainer
Hype vs. Reality: The AI ExplainerHype vs. Reality: The AI Explainer
Hype vs. Reality: The AI Explainer
 
Study: The Future of VR, AR and Self-Driving Cars
Study: The Future of VR, AR and Self-Driving CarsStudy: The Future of VR, AR and Self-Driving Cars
Study: The Future of VR, AR and Self-Driving Cars
 

Similar to Corporates 2010

C:\Documents And Settings\Aghezzi\Desktop\Property Tax\2009 Nh Property Taxes
C:\Documents And Settings\Aghezzi\Desktop\Property Tax\2009 Nh Property TaxesC:\Documents And Settings\Aghezzi\Desktop\Property Tax\2009 Nh Property Taxes
C:\Documents And Settings\Aghezzi\Desktop\Property Tax\2009 Nh Property Taxesoutdoormojo
 
Global CDO market Issuance Data
Global CDO market Issuance DataGlobal CDO market Issuance Data
Global CDO market Issuance Datafinancedude
 
Withholding tax response 2011
Withholding tax response 2011Withholding tax response 2011
Withholding tax response 2011Mohammad Azam
 
Ενδέκατη Εβδομάδα Τιμώμενου Μέλους
Ενδέκατη Εβδομάδα Τιμώμενου ΜέλουςΕνδέκατη Εβδομάδα Τιμώμενου Μέλους
Ενδέκατη Εβδομάδα Τιμώμενου Μέλουςmpiskotos
 
Indicadores dic2008
Indicadores dic2008Indicadores dic2008
Indicadores dic2008redasomi
 
Stock Indicies
Stock IndiciesStock Indicies
Stock Indiciesukabuka
 
현대커머셜 IR 자료 2011년1분기 국문
현대커머셜 IR 자료 2011년1분기 국문 현대커머셜 IR 자료 2011년1분기 국문
현대커머셜 IR 자료 2011년1분기 국문 Hyundai Finance
 
Δωδέκατη Εβδομάδα Τιμώμενου Μέλους
Δωδέκατη Εβδομάδα Τιμώμενου ΜέλουςΔωδέκατη Εβδομάδα Τιμώμενου Μέλους
Δωδέκατη Εβδομάδα Τιμώμενου Μέλουςmpiskotos
 
Maiz grano para blog
Maiz grano para blogMaiz grano para blog
Maiz grano para blogMiguel Lopez
 

Similar to Corporates 2010 (20)

Excel Básico 1
Excel Básico 1Excel Básico 1
Excel Básico 1
 
Frijol para blog
Frijol para blogFrijol para blog
Frijol para blog
 
C:\Documents And Settings\Aghezzi\Desktop\Property Tax\2009 Nh Property Taxes
C:\Documents And Settings\Aghezzi\Desktop\Property Tax\2009 Nh Property TaxesC:\Documents And Settings\Aghezzi\Desktop\Property Tax\2009 Nh Property Taxes
C:\Documents And Settings\Aghezzi\Desktop\Property Tax\2009 Nh Property Taxes
 
Global CDO market Issuance Data
Global CDO market Issuance DataGlobal CDO market Issuance Data
Global CDO market Issuance Data
 
Sorgo para blog
Sorgo para blogSorgo para blog
Sorgo para blog
 
Mango para blog
Mango para blogMango para blog
Mango para blog
 
2011 Test Plot Book
2011 Test Plot Book2011 Test Plot Book
2011 Test Plot Book
 
Petrotrim Pipe Schedules
Petrotrim Pipe SchedulesPetrotrim Pipe Schedules
Petrotrim Pipe Schedules
 
Withholding tax response 2011
Withholding tax response 2011Withholding tax response 2011
Withholding tax response 2011
 
Grilla Psicologia 2011
Grilla  Psicologia 2011Grilla  Psicologia 2011
Grilla Psicologia 2011
 
Grilla Especial 2011
Grilla  Especial 2011Grilla  Especial 2011
Grilla Especial 2011
 
Aga table
Aga tableAga table
Aga table
 
Ενδέκατη Εβδομάδα Τιμώμενου Μέλους
Ενδέκατη Εβδομάδα Τιμώμενου ΜέλουςΕνδέκατη Εβδομάδα Τιμώμενου Μέλους
Ενδέκατη Εβδομάδα Τιμώμενου Μέλους
 
Fondos Recibidos Por Ayuntamientos 1999 2005 úLtimo
Fondos Recibidos Por Ayuntamientos 1999 2005 úLtimoFondos Recibidos Por Ayuntamientos 1999 2005 úLtimo
Fondos Recibidos Por Ayuntamientos 1999 2005 úLtimo
 
Indicadores dic2008
Indicadores dic2008Indicadores dic2008
Indicadores dic2008
 
Stock Indicies
Stock IndiciesStock Indicies
Stock Indicies
 
Grilla Superior 2011
Grilla  Superior 2011Grilla  Superior 2011
Grilla Superior 2011
 
현대커머셜 IR 자료 2011년1분기 국문
현대커머셜 IR 자료 2011년1분기 국문 현대커머셜 IR 자료 2011년1분기 국문
현대커머셜 IR 자료 2011년1분기 국문
 
Δωδέκατη Εβδομάδα Τιμώμενου Μέλους
Δωδέκατη Εβδομάδα Τιμώμενου ΜέλουςΔωδέκατη Εβδομάδα Τιμώμενου Μέλους
Δωδέκατη Εβδομάδα Τιμώμενου Μέλους
 
Maiz grano para blog
Maiz grano para blogMaiz grano para blog
Maiz grano para blog
 

Recently uploaded

TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024Adnet Communications
 
Healthcare Feb. & Mar. Healthcare Newsletter
Healthcare Feb. & Mar. Healthcare NewsletterHealthcare Feb. & Mar. Healthcare Newsletter
Healthcare Feb. & Mar. Healthcare NewsletterJamesConcepcion7
 
NAB Show Exhibitor List 2024 - Exhibitors Data
NAB Show Exhibitor List 2024 - Exhibitors DataNAB Show Exhibitor List 2024 - Exhibitors Data
NAB Show Exhibitor List 2024 - Exhibitors DataExhibitors Data
 
WSMM Media and Entertainment Feb_March_Final.pdf
WSMM Media and Entertainment Feb_March_Final.pdfWSMM Media and Entertainment Feb_March_Final.pdf
WSMM Media and Entertainment Feb_March_Final.pdfJamesConcepcion7
 
Appkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptxAppkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptxappkodes
 
Technical Leaders - Working with the Management Team
Technical Leaders - Working with the Management TeamTechnical Leaders - Working with the Management Team
Technical Leaders - Working with the Management TeamArik Fletcher
 
Pitch Deck Teardown: Xpanceo's $40M Seed deck
Pitch Deck Teardown: Xpanceo's $40M Seed deckPitch Deck Teardown: Xpanceo's $40M Seed deck
Pitch Deck Teardown: Xpanceo's $40M Seed deckHajeJanKamps
 
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdfGUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdfDanny Diep To
 
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...ssuserf63bd7
 
Send Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSendBig4
 
Excvation Safety for safety officers reference
Excvation Safety for safety officers referenceExcvation Safety for safety officers reference
Excvation Safety for safety officers referencessuser2c065e
 
Entrepreneurship lessons in Philippines
Entrepreneurship lessons in  PhilippinesEntrepreneurship lessons in  Philippines
Entrepreneurship lessons in PhilippinesDavidSamuel525586
 
Unveiling the Soundscape Music for Psychedelic Experiences
Unveiling the Soundscape Music for Psychedelic ExperiencesUnveiling the Soundscape Music for Psychedelic Experiences
Unveiling the Soundscape Music for Psychedelic ExperiencesDoe Paoro
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMVoces Mineras
 
Effective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold JewelryEffective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold JewelryWhittensFineJewelry1
 
Welding Electrode Making Machine By Deccan Dynamics
Welding Electrode Making Machine By Deccan DynamicsWelding Electrode Making Machine By Deccan Dynamics
Welding Electrode Making Machine By Deccan DynamicsIndiaMART InterMESH Limited
 
WSMM Technology February.March Newsletter_vF.pdf
WSMM Technology February.March Newsletter_vF.pdfWSMM Technology February.March Newsletter_vF.pdf
WSMM Technology February.March Newsletter_vF.pdfJamesConcepcion7
 
Introducing the Analogic framework for business planning applications
Introducing the Analogic framework for business planning applicationsIntroducing the Analogic framework for business planning applications
Introducing the Analogic framework for business planning applicationsKnowledgeSeed
 
How Generative AI Is Transforming Your Business | Byond Growth Insights | Apr...
How Generative AI Is Transforming Your Business | Byond Growth Insights | Apr...How Generative AI Is Transforming Your Business | Byond Growth Insights | Apr...
How Generative AI Is Transforming Your Business | Byond Growth Insights | Apr...Hector Del Castillo, CPM, CPMM
 

Recently uploaded (20)

TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024
 
Healthcare Feb. & Mar. Healthcare Newsletter
Healthcare Feb. & Mar. Healthcare NewsletterHealthcare Feb. & Mar. Healthcare Newsletter
Healthcare Feb. & Mar. Healthcare Newsletter
 
NAB Show Exhibitor List 2024 - Exhibitors Data
NAB Show Exhibitor List 2024 - Exhibitors DataNAB Show Exhibitor List 2024 - Exhibitors Data
NAB Show Exhibitor List 2024 - Exhibitors Data
 
WSMM Media and Entertainment Feb_March_Final.pdf
WSMM Media and Entertainment Feb_March_Final.pdfWSMM Media and Entertainment Feb_March_Final.pdf
WSMM Media and Entertainment Feb_March_Final.pdf
 
Appkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptxAppkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptx
 
Technical Leaders - Working with the Management Team
Technical Leaders - Working with the Management TeamTechnical Leaders - Working with the Management Team
Technical Leaders - Working with the Management Team
 
Pitch Deck Teardown: Xpanceo's $40M Seed deck
Pitch Deck Teardown: Xpanceo's $40M Seed deckPitch Deck Teardown: Xpanceo's $40M Seed deck
Pitch Deck Teardown: Xpanceo's $40M Seed deck
 
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdfGUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
 
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
 
Send Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.com
 
Excvation Safety for safety officers reference
Excvation Safety for safety officers referenceExcvation Safety for safety officers reference
Excvation Safety for safety officers reference
 
Entrepreneurship lessons in Philippines
Entrepreneurship lessons in  PhilippinesEntrepreneurship lessons in  Philippines
Entrepreneurship lessons in Philippines
 
Unveiling the Soundscape Music for Psychedelic Experiences
Unveiling the Soundscape Music for Psychedelic ExperiencesUnveiling the Soundscape Music for Psychedelic Experiences
Unveiling the Soundscape Music for Psychedelic Experiences
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQM
 
Effective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold JewelryEffective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold Jewelry
 
Welding Electrode Making Machine By Deccan Dynamics
Welding Electrode Making Machine By Deccan DynamicsWelding Electrode Making Machine By Deccan Dynamics
Welding Electrode Making Machine By Deccan Dynamics
 
WSMM Technology February.March Newsletter_vF.pdf
WSMM Technology February.March Newsletter_vF.pdfWSMM Technology February.March Newsletter_vF.pdf
WSMM Technology February.March Newsletter_vF.pdf
 
Introducing the Analogic framework for business planning applications
Introducing the Analogic framework for business planning applicationsIntroducing the Analogic framework for business planning applications
Introducing the Analogic framework for business planning applications
 
How Generative AI Is Transforming Your Business | Byond Growth Insights | Apr...
How Generative AI Is Transforming Your Business | Byond Growth Insights | Apr...How Generative AI Is Transforming Your Business | Byond Growth Insights | Apr...
How Generative AI Is Transforming Your Business | Byond Growth Insights | Apr...
 
The Bizz Quiz-E-Summit-E-Cell-IITPatna.pptx
The Bizz Quiz-E-Summit-E-Cell-IITPatna.pptxThe Bizz Quiz-E-Summit-E-Cell-IITPatna.pptx
The Bizz Quiz-E-Summit-E-Cell-IITPatna.pptx
 

Corporates 2010

  • 1. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 1 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% TOTAL MARKET 4,068.97 100 5.8 46,781.00 100 23.5 46,781.00 100 16.5 100 1.2 1,022,388 1 1 1 CIPLA 953 224.84 5.53 5 2,437.01 5.21 21.3 2,437.01 5.21 14.4 98 0.5 53,272 * CIPLA 953 224.84 5.53 5 2,437.01 5.21 21.3 2,437.01 5.21 14.4 98 0.5 53,272 2 2 2 RANBAXY* 651 195.12 4.8 3.8 2,186.16 4.67 17.9 2,186.16 4.67 11.2 95 1.3 47,793 * CROSLANDS 85 16.77 0.41 18.4 181.26 0.39 19.7 181.26 0.39 12.8 97 0.1 3,964 * RANBAXY 463 85.30 2.1 0.6 981.37 2.1 17.8 981.37 2.1 11.2 95 2.7 21,454 * RANBAXY GLOBAL CHC 13 28.13 0.69 6.1 289.42 0.62 30.6 289.42 0.62 23.4 106 0.6 6329 + REXCEL 26 25.22 0.62 4.3 281.05 0.6 15.5 281.05 0.6 9 94 6,139 SOLUS 33 4.55 0.11 6.3 52.30 0.11 6.6 52.30 0.11 0.4 86 1,143 STANCARE 31 35.15 0.86 3.2 400.77 0.86 12.5 400.77 0.86 6 91 8763 3 3 3 GLAXOSMITHKLINE* 180 169.81 4.17 2.5 1,979.41 4.23 20.3 1,979.41 4.23 13.6 97 0.1 43,258 * GLAXOSMITHKLINE 172 167.43 4.11 2.7 1,947.75 4.16 20.6 1,947.75 4.16 13.8 98 0.1 42,567 GSK CONSUMER HC 8 2.38 0.06 -11.5 31.66 0.07 7.6 31.66 0.07 1.5 87 692 4 4 4 PIRAMALHEALTHCARE* 783 163.73 4.02 2.9 1,892.24 4.04 18 1,892.24 4.04 11.4 96 1.3 41,352 * PIRAMAL HEALTHCARE 783 163.73 4.02 2.9 1,892.24 4.04 18 1,892.24 4.04 11.4 96 1.3 41,352 5 5 6 ZYDUS CADILA* 777 153.02 3.76 4.4 1,747.47 3.74 24.7 1,747.47 3.74 17.7 101 1.2 38,192 * GERMAN REMEDIES 268 45.54 1.12 -3.5 512.83 1.1 20.6 512.83 1.1 13.8 98 1.1 11,208 * LIVA HEALTHCARE 53 10.04 0.25 22.3 91.78 0.2 33.9 91.78 0.2 26.7 109 0.8 2,007 RECON 16 0.00 0 -87.7 0.13 0 7.3 0.13 0 2.3 88 3 * ZYDUS CADILA 440 97.45 2.39 6.9 1,142.73 2.44 25.9 1,142.73 2.44 18.8 102 1.3 24974 21.89 6 6 5 SUN* 549 156.91 3.86 11.3 1,717.38 3.67 25.5 1,717.38 3.67 18.4 102 0.9 37,542 MILMET LABS 21 2.55 0.06 13 28.24 0.06 18.7 28.24 0.06 11.9 96 617 SOLARES 24 3.58 0.09 -4.9 36.18 0.08 12.9 36.18 0.08 6.8 92 791 * SUN PHARMA 504 150.79 3.71 11.7 1,652.97 3.53 26 1,652.97 3.53 18.8 102 0.9 36,134 7 7 9 ALKEM* 708 126.17 3.1 1.3 1,544.73 3.3 26.3 1,544.73 3.3 19.3 102 1.4 33754 * ALKEM 555 110.96 2.73 1.1 1,348.83 2.88 25.7 1,348.83 2.88 18.7 102 1.4 29,474 * CACHET 85 9.18 0.23 -2.1 125.71 0.27 32.1 125.71 0.27 24.8 107 1 2746 * INDCHEMIE 68 6.03 0.15 11.7 70.19 0.15 28.8 70.19 0.15 21.6 104 1.4 1,533 8 8 8 MANKIND 507 126.84 3.12 12.3 1,480.26 3.16 41.6 1,480.26 3.16 33.8 115 2.3 32,347 * MANKIND 507 126.84 3.12 12.3 1,480.26 3.16 41.6 1,480.26 3.16 33.8 115 2.3 32,347 9 9 10 PFIZER* 149 119.90 2.95 1.4 1,474.28 3.15 27.9 1,474.28 3.15 20.7 104 0.4 32,224 PARKE DAVIS 30 13.32 0.33 6.1 165.40 0.35 26.3 165.40 0.35 19.2 102 3,614 * PFIZER 45 58.51 1.44 -7.4 768.23 1.64 29 768.23 1.64 21.7 104 0.4 16791 IMS, ALL RIGHTS RESERVED
  • 2. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 2 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% PHARMACIA 25 8.01 0.2 -3.1 98.82 0.21 26.2 98.82 0.21 19.2 102 2,160 PHARMACIA HEALTH 13 6.08 0.15 11.8 62.10 0.13 28.3 62.10 0.13 21.2 104 1357 * WYETH LIMITED 36 33.99 0.84 17.8 379.73 0.81 26.7 379.73 0.81 19.4 103 0.8 8301 10 10 7 ABBOTT* 140 127.96 3.14 20.3 1,387.98 2.97 33.4 1,387.98 2.97 25.8 108 1 30,345 * ABBOTT 113 105.89 2.6 19.2 1,145.91 2.45 33 1,145.91 2.45 25.5 108 1.2 25,054 * SOLVAY PHARMA 27 22.07 0.54 25.9 242.07 0.52 34.9 242.07 0.52 27.2 109 0.1 5,291 38.15 11 11 11 LUPIN LIMITED 603 113.63 2.79 7.1 1,272.88 2.72 22.8 1,272.88 2.72 15.9 99 2.2 27818 * LUPIN LIMITED 603 113.63 2.79 7.1 1,272.88 2.72 22.8 1,272.88 2.72 15.9 99 2.2 27,818 12 12 15 ARISTO PHARMA* 253 88.74 2.18 -3.8 1,122.65 2.4 23.1 1,122.65 2.4 16.2 100 0.9 24,530 * ARISTO PHARMA 154 73.96 1.82 -4.1 940.08 2.01 23.8 940.08 2.01 16.9 100 0.8 20541 * GENETICA 99 14.77 0.36 -2.3 182.57 0.39 19.3 182.57 0.39 12.5 97 1.4 3,989 13 13 12 INTAS PHARMA* 773 96.64 2.38 25.3 1,022.38 2.19 39 1,022.38 2.19 31.2 113 1.6 22,350 ANDRE LABS 17 0.93 0.02 -2.3 10.94 0.02 8.2 10.94 0.02 2 88 239 * INTAS 756 95.71 2.35 25.6 1,011.44 2.16 39.5 1,011.44 2.16 31.7 113 1.6 22,111 14 14 13 DR REDDYS LABS 264 89.89 2.21 1.9 1,013.77 2.17 18.9 1,013.77 2.17 12.2 96 1 22149 * DR REDDYS LABS 264 89.89 2.21 1.9 1,013.77 2.17 18.9 1,013.77 2.17 12.2 96 1 22,149 15 15 16 SANOFI AVENTIS* 128 88.51 2.18 6.5 1,008.92 2.16 27.6 1,008.92 2.16 20.4 103 1.1 22053 * SANOFI AVENTIS 94 85.05 2.09 9.2 967.86 2.07 29.5 967.86 2.07 22.2 105 1.2 21,156 + SANOFI PASTEUR 18 3.27 0.08 -24 36.36 0.08 0.4 36.36 0.08 -5.2 81 795 + SHANTHA BIOTECH 16 0.18 0 -79.1 4.70 0.01 -34.4 4.70 0.01 -37.8 53 102 49.78 16 16 19 EMCURE* 437 81.58 2 13.9 952.02 2.04 26.2 952.02 2.04 19 102 1.8 20,805 * EMCURE 295 51.49 1.27 21 592.41 1.27 27.3 592.41 1.27 20 103 1.6 12,948 * ZUVENTUS PHARMA 142 30.08 0.74 3.4 359.61 0.77 24.3 359.61 0.77 17.4 101 2.3 7,857 17 17 14 MACLEODS PHARMA 282 88.86 2.18 31.7 941.05 2.01 47.6 941.05 2.01 39.4 120 3.1 20,574 * MACLEODS PHARMA 282 88.86 2.18 31.7 941.05 2.01 47.6 941.05 2.01 39.4 120 3.1 20574 18 18 18 TORRENT PHARMA 378 83.67 2.06 12.7 933.62 2 23 933.62 2 15.9 99 1.6 20,410 * TORRENT PHARMA 378 83.67 2.06 12.7 933.62 2 23 933.62 2 15.9 99 1.6 20410 19 19 17 WOCKHARDT-MERIND* 480 84.25 2.07 11.5 922.44 1.97 20.4 922.44 1.97 13.5 97 0.7 20,162 DUMEX 23 1.81 0.04 -12.4 25.93 0.06 51.9 25.93 0.06 43.7 123 567 + MERIND 72 15.24 0.37 -6.2 185.57 0.4 12.4 185.57 0.4 6 91 4056 * WOCKHARDT 385 67.20 1.65 17.4 710.94 1.52 21.7 710.94 1.52 14.7 98 0.9 15,540 20 20 20 ALEMBIC 356 75.09 1.85 -2.4 843.42 1.8 15.2 843.42 1.8 8.8 93 0.8 18430 IMS, ALL RIGHTS RESERVED
  • 3. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 3 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% * ALEMBIC 356 75.09 1.85 -2.4 843.42 1.8 15.2 843.42 1.8 8.8 93 0.8 18,430 59.6 21 21 23 MICRO LABS* 654 72.63 1.78 4.5 817.39 1.75 18.4 817.39 1.75 11.8 96 1.3 17861 * BAL PHARMA 86 2.30 0.06 -17.5 27.54 0.06 -9.5 27.54 0.06 -14.6 73 0.3 602 * MICRO LABS 568 70.33 1.73 5.4 789.85 1.69 19.7 789.85 1.69 13 97 1.3 17,259 22 22 21 NOVARTIS INTL.* 202 74.09 1.82 6.6 806.42 1.72 24.8 806.42 1.72 17.7 101 0.2 17628 * NOVARTIS 103 65.80 1.62 8.3 708.84 1.52 27 708.84 1.52 19.8 103 0.2 15,496 * SANDOZ 99 8.29 0.2 -5.4 97.58 0.21 10.5 97.58 0.21 4.2 89 0.2 2,133 23 23 22 USV 171 73.17 1.8 17.2 787.81 1.68 29.4 787.81 1.68 22.1 105 0.7 17,220 * USV 171 73.17 1.8 17.2 787.81 1.68 29.4 787.81 1.68 22.1 105 0.7 17,220 24 24 26 FDC 213 58.36 1.43 -11.4 775.60 1.66 22.6 775.60 1.66 15.7 99 0.9 16949 * FDC 213 58.36 1.43 -11.4 775.60 1.66 22.6 775.60 1.66 15.7 99 0.9 16,949 25 25 24 GLENMARK PHARMA 240 68.22 1.68 15.5 718.92 1.54 31.4 718.92 1.54 24 106 2.3 15712 * GLENMARK PHARMA 240 68.22 1.68 15.5 718.92 1.54 31.4 718.92 1.54 24 106 2.3 15,712 67.95 26 26 25 UNICHEM* 275 60.82 1.49 6.9 702.75 1.5 23.3 702.75 1.5 16.3 100 0.9 15357 * UNICHEM 247 39.33 0.97 6.9 455.96 0.97 24.8 455.96 0.97 17.8 101 1.2 9,963 * UNISEARCH 28 21.48 0.53 7 246.80 0.53 20.5 246.80 0.53 13.6 97 0.3 5,394 27 27 27 IPCA LABS 211 50.92 1.25 1.7 675.53 1.44 29.6 675.53 1.44 22.4 105 1 14,757 * IPCA LABS 211 50.92 1.25 1.7 675.53 1.44 29.6 675.53 1.44 22.4 105 1 14,757 28 28 28 ELDER PHARMA 303 44.25 1.09 13.4 498.33 1.07 36.7 498.33 1.07 29.2 111 4.4 10,892 * ELDER PHARMA 303 44.25 1.09 13.4 498.33 1.07 36.7 498.33 1.07 29.2 111 4.4 10,892 29 29 29 FRANCO INDIAN 84 37.47 0.92 3.7 419.21 0.9 17.5 419.21 0.9 11 95 1.7 9,159 * FRANCO INDIAN 84 37.47 0.92 3.7 419.21 0.9 17.5 419.21 0.9 11 95 1.7 9,159 30 30 30 MERCK LIMITED 112 34.38 0.84 10 415.08 0.89 27.2 415.08 0.89 20 103 0.9 9,068 * MERCK LIMITED 112 34.38 0.84 10 415.08 0.89 27.2 415.08 0.89 20 103 0.9 9,068 73.74 31 31 33 CADILA PHARMA 398 31.63 0.78 -3.4 408.16 0.87 18.2 408.16 0.87 11.4 96 0.4 8,922 * CADILA PHARMA 398 31.63 0.78 -3.4 408.16 0.87 18.2 408.16 0.87 11.4 96 0.4 8,922 32 32 32 MSD PHARMACEUTICAL 80 32.86 0.81 -7.4 405.89 0.87 16.4 405.89 0.87 9.9 94 0.4 8,869 + FULFORD INDIA 30 10.92 0.27 -13.9 138.74 0.3 4.4 138.74 0.3 -1.5 85 3,031 * MSD PHARMACEUTICAL 10 10.24 0.25 7.3 123.36 0.26 68.5 123.36 0.26 59.8 137 1.5 2,696 + ORGANON 40 11.69 0.29 -11.9 143.79 0.31 0.8 143.79 0.31 -4.9 82 3142 IMS, ALL RIGHTS RESERVED
  • 4. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 4 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% 33 33 31 INDOCO* 309 33.56 0.82 -4.4 404.63 0.86 19 404.63 0.86 12.5 97 0.9 8,838 * INDOCO 264 27.19 0.67 -7.1 332.24 0.71 18.4 332.24 0.71 11.9 96 1 7,256 * WARREN 45 6.37 0.16 9 72.39 0.15 21.9 72.39 0.15 14.9 99 0.1 1582 34 34 34 HIMALAYA DRUG 108 31.10 0.76 6.4 366.92 0.78 21 366.92 0.78 14.1 98 0.3 8,020 * HIMALAYA DRUG 108 31.10 0.76 6.4 366.92 0.78 21 366.92 0.78 14.1 98 0.3 8020 35 35 35 ASTRAZENECA 57 26.58 0.65 8.6 273.49 0.58 20.8 273.49 0.58 14 98 0.9 5,979 * ASTRAZENECA 57 26.58 0.65 8.6 273.49 0.58 20.8 273.49 0.58 14 98 0.9 5979 77.72 36 36 36 BLUE CROSS 144 23.76 0.58 9.4 262.14 0.56 26 262.14 0.56 19.1 102 1.4 5,727 * BLUE CROSS 144 23.76 0.58 9.4 262.14 0.56 26 262.14 0.56 19.1 102 1.4 5727 37 37 37 UNIQUE PHARM 126 20.41 0.5 6.8 246.75 0.53 23.4 246.75 0.53 16.4 100 0.4 5,392 * UNIQUE PHARM 126 20.41 0.5 6.8 246.75 0.53 23.4 246.75 0.53 16.4 100 0.4 5392 38 38 39 BIOCHEM 293 19.02 0.47 0.8 231.38 0.49 28.2 231.38 0.49 21 104 0.4 5,058 * BIOCHEM 293 19.02 0.47 0.8 231.38 0.49 28.2 231.38 0.49 21 104 0.4 5058 39 39 41 MEDLEY PHARMA 246 17.11 0.42 -1.3 228.78 0.49 29.6 228.78 0.49 22.4 105 0.5 4,998 * MEDLEY PHARMA 246 17.11 0.42 -1.3 228.78 0.49 29.6 228.78 0.49 22.4 105 0.5 4998 40 40 38 WIN MEDICARE 59 19.49 0.48 9.7 220.54 0.47 32.9 220.54 0.47 25.5 108 0.1 4,819 * WIN MEDICARE 59 19.49 0.48 9.7 220.54 0.47 32.9 220.54 0.47 25.5 108 0.1 4819 80.26 41 41 42 RAPTAKOS BRETT 62 16.82 0.41 4.2 218.03 0.47 18.8 218.03 0.47 12 96 4,764 RAPTAKOS BRETT 62 16.82 0.41 4.2 218.03 0.47 18.8 218.03 0.47 12 96 4764 42 42 40 WALLACE 104 17.70 0.44 11.7 210.69 0.45 29 210.69 0.45 21.6 104 1.4 4,604 * WALLACE 104 17.70 0.44 11.7 210.69 0.45 29 210.69 0.45 21.6 104 1.4 4604 43 43 45 SHREYA LIFE SCIENC 222 15.22 0.37 -10.3 197.40 0.42 6 197.40 0.42 0 86 0.4 4,312 * PLETHICO 128 7.33 0.18 -17.3 95.95 0.21 3.9 95.95 0.21 -1.8 84 0.7 2096 * SHREYA LIFESCIENCE 94 7.89 0.19 -2.7 101.45 0.22 8 101.45 0.22 1.8 87 0 2,217 44 44 43 JANSSEN-CILAG 40 16.41 0.4 10.3 190.12 0.41 25.4 190.12 0.41 18.3 102 1.6 4,155 * JANSSEN-CILAG 40 16.41 0.4 10.3 190.12 0.41 25.4 190.12 0.41 18.3 102 1.6 4155 45 45 52 WANBURY 82 12.76 0.31 -20.1 186.39 0.4 19.5 186.39 0.4 12.9 97 3.9 4,072 * WANBURY 82 12.76 0.31 -20.1 186.39 0.4 19.5 186.39 0.4 12.9 97 3.9 4072 82.4 46 46 50 MANEESH PHARMA* 202 13.62 0.33 -4.4 175.60 0.38 13 175.60 0.38 6.7 92 0.3 3,836 + MANEESH HEALTHCARE 72 2.91 0.07 -13.7 37.07 0.08 3.3 37.07 0.08 -2.5 84 810 IMS, ALL RIGHTS RESERVED
  • 5. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 5 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% SMYLE 2 0.06 0 -40.5 1.11 0 -6.4 1.11 0 -11.5 76 24 * SVIZERA HEALTHCARE 128 10.65 0.26 -1.1 137.42 0.29 16.2 137.42 0.29 9.7 94 0.4 3,002 47 47 46 PANACEA BIOTEC 146 15.06 0.37 1.7 173.94 0.37 14.6 173.94 0.37 8.1 93 1.3 3,801 * PANACEA BIOTEC 146 15.06 0.37 1.7 173.94 0.37 14.6 173.94 0.37 8.1 93 1.3 3,801 48 48 44 HETERO HEALTHCARE* 118 15.96 0.39 12.9 173.39 0.37 23.5 173.39 0.37 16.7 100 4 3,788 * GENIX 48 6.41 0.16 31.1 65.79 0.14 40.9 65.79 0.14 33.1 114 2.4 1437 * HETERO HEALTHCARE 70 9.56 0.23 3.2 107.60 0.23 14.8 107.60 0.23 8.5 93 5.1 2,350 49 49 47 MEYER ORGANICS 110 14.54 0.36 15.8 167.82 0.36 33.1 167.82 0.36 25.7 108 1.6 3,667 * MEYER ORGANICS 110 14.54 0.36 15.8 167.82 0.36 33.1 167.82 0.36 25.7 108 1.6 3,667 50 50 49 APEX 72 13.78 0.34 5.7 163.53 0.35 21.1 163.53 0.35 14.4 98 0 3,573 * APEX 72 13.78 0.34 5.7 163.53 0.35 21.1 163.53 0.35 14.4 98 0 3573 84.23 51 51 54 ALBERT DAVID 72 12.39 0.3 14.8 156.19 0.33 21.6 156.19 0.33 14.6 98 0.6 3,414 * ALBERT DAVID 72 12.39 0.3 14.8 156.19 0.33 21.6 156.19 0.33 14.6 98 0.6 3414 52 52 51 SYSTOPIC 104 13.01 0.32 15.9 147.51 0.32 32.8 147.51 0.32 25.2 107 1.2 3,224 * SYSTOPIC 104 13.01 0.32 15.9 147.51 0.32 32.8 147.51 0.32 25.2 107 1.2 3,224 53 53 48 CENTAUR 114 13.85 0.34 -2.1 144.16 0.31 17.6 144.16 0.31 11.2 95 0.7 3149 * CENTAUR 114 13.85 0.34 -2.1 144.16 0.31 17.6 144.16 0.31 11.2 95 0.7 3,149 54 54 60 GENO 56 11.21 0.28 2.6 141.80 0.3 38.4 141.80 0.3 30.7 112 1 3098 * GENO 56 11.21 0.28 2.6 141.80 0.3 38.4 141.80 0.3 30.7 112 1 3,098 55 55 55 DABUR 372 12.25 0.3 -19.5 141.13 0.3 -11.5 141.13 0.3 -16.6 72 0.1 3085 * DABUR 372 12.25 0.3 -19.5 141.13 0.3 -11.5 141.13 0.3 -16.6 72 0.1 3,085 85.79 56 56 53 FOURTS INDIA 122 12.56 0.31 13.1 140.43 0.3 22.5 140.43 0.3 15.5 99 1.4 3069 * FOURTS INDIA 122 12.56 0.31 13.1 140.43 0.3 22.5 140.43 0.3 15.5 99 1.4 3,069 57 57 61 IND-SWIFT 453 10.83 0.27 -17.4 138.94 0.3 4.9 138.94 0.3 -1 85 0.9 3036 * IND-SWIFT 453 10.83 0.27 -17.4 138.94 0.3 4.9 138.94 0.3 -1 85 0.9 3,036 58 58 64 BESTOCHEM 147 9.99 0.25 -2.9 134.46 0.29 22.8 134.46 0.29 15.9 99 2.3 2937 * BESTOCHEM 147 9.99 0.25 -2.9 134.46 0.29 22.8 134.46 0.29 15.9 99 2.3 2,937 59 59 57 ELI LILLY 22 11.76 0.29 8.4 129.38 0.28 23.7 129.38 0.28 16.7 100 0 2828 * ELI LILLY 22 11.76 0.29 8.4 129.38 0.28 23.7 129.38 0.28 16.7 100 0 2,828 IMS, ALL RIGHTS RESERVED
  • 6. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 6 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% 60 60 63 ALLERGAN 43 10.35 0.25 15.7 123.49 0.26 37.1 123.49 0.26 29.3 111 4.7 2700 * ALLERGAN 43 10.35 0.25 15.7 123.49 0.26 37.1 123.49 0.26 29.3 111 4.7 2,700 87.22 61 61 56 HEGDE & HEGDE 46 11.88 0.29 19.4 122.92 0.26 35.8 122.92 0.26 28.4 110 2687 HEGDE & HEGDE 46 11.88 0.29 19.4 122.92 0.26 35.8 122.92 0.26 28.4 110 2,687 62 62 58 AJANTA PHARMA 147 11.51 0.28 13.3 122.74 0.26 19.2 122.74 0.26 12.3 96 2.9 2684 * AJANTA PHARMA 147 11.51 0.28 13.3 122.74 0.26 19.2 122.74 0.26 12.3 96 2.9 2,684 63 63 67 CFL 98 9.52 0.23 -5.9 121.28 0.26 5.1 121.28 0.26 -1 85 0.4 2650 * CFL 98 9.52 0.23 -5.9 121.28 0.26 5.1 121.28 0.26 -1 85 0.4 2,650 64 64 65 CHARAK PHARMA 60 9.93 0.24 -0.1 121.00 0.26 15.6 121.00 0.26 9.1 94 0 2643 * CHARAK PHARMA 60 9.93 0.24 -0.1 121.00 0.26 15.6 121.00 0.26 9.1 94 0 2,643 65 65 59 ORCHID CHEM&PHARM* 172 11.29 0.28 9.5 120.76 0.26 17.7 120.76 0.26 11 95 1.2 2639 * ORCHID CHEM&PHARMA 172 11.29 0.28 9.5 120.76 0.26 17.7 120.76 0.26 11 95 1.2 2,639 88.52 66 66 66 MODI MUNDIPHARMA 31 9.84 0.24 -11.8 116.37 0.25 10.8 116.37 0.25 4.5 90 0.1 2543 * MODI MUNDIPHARMA 31 9.84 0.24 -11.8 116.37 0.25 10.8 116.37 0.25 4.5 90 0.1 2,543 67 67 73 EAST INDIA 34 7.69 0.19 0 105.85 0.23 27.7 105.85 0.23 20.4 103 0 2313 * EAST INDIA 34 7.69 0.19 0 105.85 0.23 27.7 105.85 0.23 20.4 103 0 2,313 68 68 69 JAGSON PAL 88 8.51 0.21 -7.4 103.52 0.22 17 103.52 0.22 10.3 95 2262 + JAGSON PAL 88 8.51 0.21 -7.4 103.52 0.22 17 103.52 0.22 10.3 95 2,262 69 69 62 BAIDYANATH 333 10.37 0.25 3.7 102.81 0.22 23.9 102.81 0.22 17.2 101 0 2248 * BAIDYANATH 333 10.37 0.25 3.7 102.81 0.22 23.9 102.81 0.22 17.2 101 0 2,248 70 70 70 SERDIA 11 8.36 0.21 9.9 97.76 0.21 31.6 97.76 0.21 24.1 107 2136 + SERDIA 11 8.36 0.21 9.9 97.76 0.21 31.6 97.76 0.21 24.1 107 2,136 89.64 71 71 68 UNIVERSAL 56 8.74 0.21 8.7 96.47 0.21 14.8 96.47 0.21 8.2 93 0.3 2108 * UNIVERSAL 56 8.74 0.21 8.7 96.47 0.21 14.8 96.47 0.21 8.2 93 0.3 2,108 72 72 72 BIOLOGICAL E 65 7.75 0.19 -11.9 95.34 0.2 6.9 95.34 0.2 0.9 87 0.5 2083 * BIOLOGICAL E 65 7.75 0.19 -11.9 95.34 0.2 6.9 95.34 0.2 0.9 87 0.5 2,083 73 73 71 UCB PHARMA 19 7.95 0.2 10.6 83.16 0.18 22.4 83.16 0.18 15.6 99 4 1818 * UCB PHARMA 19 7.95 0.2 10.6 83.16 0.18 22.4 83.16 0.18 15.6 99 4 1,818 74 74 74 BIOCON 50 7.53 0.18 19.5 82.74 0.18 25.2 82.74 0.18 18 101 3.6 1808 IMS, ALL RIGHTS RESERVED
  • 7. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 7 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% * BIOCON 50 7.53 0.18 19.5 82.74 0.18 25.2 82.74 0.18 18 101 3.6 1,808 75 75 90 DEY S 46 5.29 0.13 -8.9 80.64 0.17 12.6 80.64 0.17 6.2 91 0.7 1762 * DEY S 46 5.29 0.13 -8.9 80.64 0.17 12.6 80.64 0.17 6.2 91 0.7 1,762 90.58 76 76 79 TABLETS INDIA 84 6.62 0.16 -6 77.61 0.17 24.1 77.61 0.17 17.3 101 0.4 1696 * TABLETS INDIA 84 6.62 0.16 -6 77.61 0.17 24.1 77.61 0.17 17.3 101 0.4 1,696 77 77 76 SERUM INSTITUTE 66 7.01 0.17 19.5 77.03 0.16 18.7 77.03 0.16 12 96 2 1683 * SERUM INSTITUTE 66 7.01 0.17 19.5 77.03 0.16 18.7 77.03 0.16 12 96 2 1,683 78 78 83 JOHNSON & JOHNSON 48 6.08 0.15 -18.5 75.90 0.16 5.4 75.90 0.16 -0.5 85 1659 + JOHNSON & JOHNSON 48 6.08 0.15 -18.5 75.90 0.16 5.4 75.90 0.16 -0.5 85 1,659 79 79 78 TTK HEALTHCARE LTD 81 6.67 0.16 10.3 74.77 0.16 24.3 74.77 0.16 17.2 101 1.8 1634 * TTK HEALTHCARE LTD 81 6.67 0.16 10.3 74.77 0.16 24.3 74.77 0.16 17.2 101 1.8 1,634 80 80 77 PHARMED 68 6.81 0.17 28.9 74.73 0.16 34 74.73 0.16 26.4 108 4.5 1633 * PHARMED 68 6.81 0.17 28.9 74.73 0.16 34 74.73 0.16 26.4 108 4.5 1,633 91.39 81 81 75 PARAS PHARMA 27 7.13 0.18 0.5 74.62 0.16 3.2 74.62 0.16 -2.5 84 0.1 1630 * PARAS PHARMA 27 7.13 0.18 0.5 74.62 0.16 3.2 74.62 0.16 -2.5 84 0.1 1,630 82 82 82 TROIKAA PHARMA 144 6.37 0.16 8.4 74.52 0.16 40 74.52 0.16 32.3 114 5.2 1628 * TROIKAA PHARMA 144 6.37 0.16 8.4 74.52 0.16 40 74.52 0.16 32.3 114 5.2 1,628 83 83 88 WALTER BUSHNELL 22 5.52 0.14 -0.4 71.98 0.15 16.4 71.98 0.15 9.8 94 1573 WALTER BUSHNELL 22 5.52 0.14 -0.4 71.98 0.15 16.4 71.98 0.15 9.8 94 1,573 84 84 87 ANGLO FRENCH DRUGS 91 5.63 0.14 -14.9 71.89 0.15 9.6 71.89 0.15 3.4 89 0.5 1571 * ANGLO FRENCH DRUGS 91 5.63 0.14 -14.9 71.89 0.15 9.6 71.89 0.15 3.4 89 0.5 1,571 85 85 80 RPG LIFE SCIENCES 186 6.58 0.16 31.4 70.64 0.15 21.5 70.64 0.15 14.4 98 2.2 1544 * RPG LIFE SCIENCES 186 6.58 0.16 31.4 70.64 0.15 21.5 70.64 0.15 14.4 98 2.2 1,544 92.17 86 86 86 BAYER PHARMA LTD. 23 5.86 0.14 -11.3 68.57 0.15 -0.4 68.57 0.15 -6 81 0.9 1498 * BAYER PHARMA LTD. 23 5.86 0.14 -11.3 68.57 0.15 -0.4 68.57 0.15 -6 81 0.9 1,498 87 87 81 NATCO PHARMA 117 6.57 0.16 2.4 66.09 0.14 7 66.09 0.14 0.8 86 3.4 1447 * NATCO PHARMA 117 6.57 0.16 2.4 66.09 0.14 7 66.09 0.14 0.8 86 3.4 1,447 88 88 84 BRITISH BIOLOGICAL 17 6.04 0.15 19.9 66.03 0.14 26 66.03 0.14 18.8 102 0.2 1443 * BRITISH BIOLOGICAL 17 6.04 0.15 19.9 66.03 0.14 26 66.03 0.14 18.8 102 0.2 1,443 IMS, ALL RIGHTS RESERVED
  • 8. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 8 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% 89 89 93 OZONE 78 4.89 0.12 -6.4 60.40 0.13 10.8 60.40 0.13 4.5 90 1320 + OZONE 78 4.89 0.12 -6.4 60.40 0.13 10.8 60.40 0.13 4.5 90 1,320 90 90 92 BHARAT SERUM 44 5.02 0.12 -7.4 58.51 0.13 8.9 58.51 0.13 2.6 88 1.4 1279 * BHARAT SERUM 44 5.02 0.12 -7.4 58.51 0.13 8.9 58.51 0.13 2.6 88 1.4 1,279 92.85 91 91 94 VERITAZ HEALTHCARE 87 4.77 0.12 11.8 55.38 0.12 33 55.38 0.12 25.8 108 4.4 1209 * VERITAZ HEALTHCARE 87 4.77 0.12 11.8 55.38 0.12 33 55.38 0.12 25.8 108 4.4 1,209 92 92 97 COMED CHEMICALS 93 4.38 0.11 -7.7 54.81 0.12 12 54.81 0.12 5.6 91 1197 + COMED CHEMICALS 93 4.38 0.11 -7.7 54.81 0.12 12 54.81 0.12 5.6 91 1,197 93 93 95 MAPRA LABS 61 4.68 0.12 2.8 54.59 0.12 5.6 54.59 0.12 -0.6 85 1193 + MAPRA LABS 61 4.68 0.12 2.8 54.59 0.12 5.6 54.59 0.12 -0.6 85 1,193 94 94 89 GALDERMA 14 5.31 0.13 11.2 51.71 0.11 29.4 51.71 0.11 22.2 105 1130 + GALDERMA 14 5.31 0.13 11.2 51.71 0.11 29.4 51.71 0.11 22.2 105 1,130 95 95 96 OVERSEAS 63 4.40 0.11 4.5 51.52 0.11 54.8 51.52 0.11 46.7 126 3 1126 * OVERSEAS 63 4.40 0.11 4.5 51.52 0.11 54.8 51.52 0.11 46.7 126 3 1,126 93.42 96 96 109 LABORATE PHARMA 140 3.48 0.09 -22.5 51.38 0.11 5.5 51.38 0.11 -0.5 85 3.1 1122 * LABORATE PHARMA 140 3.48 0.09 -22.5 51.38 0.11 5.5 51.38 0.11 -0.5 85 3.1 1,122 97 97 100 JENBURKT 57 4.15 0.1 -9 51.35 0.11 14.8 51.35 0.11 8.4 93 1122 + JENBURKT 57 4.15 0.1 -9 51.35 0.11 14.8 51.35 0.11 8.4 93 1,122 98 98 105 KHANDELWAL 141 3.88 0.1 -17.7 51.27 0.11 2.2 51.27 0.11 -3.5 83 0.4 1120 * KHANDELWAL 141 3.88 0.1 -17.7 51.27 0.11 2.2 51.27 0.11 -3.5 83 0.4 1,120 99 99 102 JUGGAT PHARMA 33 3.97 0.1 7.6 50.88 0.11 17.5 50.88 0.11 10.8 95 1112 + JUGGAT PHARMA 33 3.97 0.1 7.6 50.88 0.11 17.5 50.88 0.11 10.8 95 1,112 100 100 91 GRANDIX 126 5.29 0.13 -1.3 50.70 0.11 -5.5 50.70 0.11 -10.8 77 1108 + GRANDIX 126 5.29 0.13 -1.3 50.70 0.11 -5.5 50.70 0.11 -10.8 77 1,108 93.97 101 101 111 AGLOWMED 60 3.42 0.08 -15.1 48.94 0.1 0.5 48.94 0.1 -5.1 81 1069 + AGLOWMED 60 3.42 0.08 -15.1 48.94 0.1 0.5 48.94 0.1 -5.1 81 1,069 102 102 101 THEMIS MEDICARE 77 4.08 0.1 -3.1 48.07 0.1 18.6 48.07 0.1 12 96 0.2 1051 * THEMIS MEDICARE 77 4.08 0.1 -3.1 48.07 0.1 18.6 48.07 0.1 12 96 0.2 1,051 IMS, ALL RIGHTS RESERVED
  • 9. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 9 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% 103 103 107 DWD PHARMACEUTICAL 72 3.76 0.09 -13 47.27 0.1 3.4 47.27 0.1 -2.3 84 2.9 1032 * DWD PHARMACEUTICAL 72 3.76 0.09 -13 47.27 0.1 3.4 47.27 0.1 -2.3 84 2.9 1,032 104 104 120 CLARIS LIFESCIENCE 66 2.89 0.07 4.4 46.88 0.1 16 46.88 0.1 9.4 94 0.5 1024 * CLARIS LIFESCIENCE 66 2.89 0.07 4.4 46.88 0.1 16 46.88 0.1 9.4 94 0.5 1,024 105 105 85 ERIS LIFE SCIENCES 55 6.01 0.15 165 46.64 0.1 301 46.64 0.1 285.4 331 12.1 1020 * ERIS LIFE SCIENCES 55 6.01 0.15 165 46.64 0.1 301 46.64 0.1 285.4 331 12.1 1,020 94.48 106 106 99 ALCON 15 4.21 0.1 29.7 45.91 0.1 45.3 45.91 0.1 37.1 118 1003 + ALCON 15 4.21 0.1 29.7 45.91 0.1 45.3 45.91 0.1 37.1 118 1,003 107 107 104 ICPA HEALTH 24 3.91 0.1 0.6 45.88 0.1 16.9 45.88 0.1 10.3 95 1003 ICPA HEALTH 24 3.91 0.1 0.6 45.88 0.1 16.9 45.88 0.1 10.3 95 1,003 108 108 98 ZANDU PHARMA 135 4.34 0.11 -10.6 45.37 0.1 -4 45.37 0.1 -9.3 78 991 ZANDU PHARMA 135 4.34 0.11 -10.6 45.37 0.1 -4 45.37 0.1 -9.3 78 991 109 109 119 HEINZ 5 2.90 0.07 9.2 44.59 0.1 21.3 44.59 0.1 13.8 98 975 HEINZ 5 2.90 0.07 9.2 44.59 0.1 21.3 44.59 0.1 13.8 98 975 110 110 110 TORQUE PHARMA 93 3.48 0.09 -27.2 43.40 0.09 8.6 43.40 0.09 2.6 88 0.3 949 * TORQUE PHARMA 93 3.48 0.09 -27.2 43.40 0.09 8.6 43.40 0.09 2.6 88 0.3 949 94.96 111 111 103 UNISON PHARMA 41 3.91 0.1 25.9 41.56 0.09 47.3 41.56 0.09 39.2 120 0.2 908 * UNISON PHARMA 41 3.91 0.1 25.9 41.56 0.09 47.3 41.56 0.09 39.2 120 0.2 908 112 112 108 NEON LABS 77 3.49 0.09 -2.1 41.22 0.09 30.5 41.22 0.09 23.4 106 0.4 900 * NEON LABS 77 3.49 0.09 -2.1 41.22 0.09 30.5 41.22 0.09 23.4 106 0.4 900 113 113 114 UNIMARCK PHARMA 89 3.33 0.08 -4.2 39.67 0.08 18.8 39.67 0.08 12 96 1 867 * UNIMARCK PHARMA 89 3.33 0.08 -4.2 39.67 0.08 18.8 39.67 0.08 12 96 1 867 114 114 113 AIMIL 23 3.41 0.08 5.3 39.43 0.08 27.6 39.43 0.08 20.4 103 862 AIMIL 23 3.41 0.08 5.3 39.43 0.08 27.6 39.43 0.08 20.4 103 862 115 115 106 PALSON DRUG 75 3.76 0.09 11.7 38.81 0.08 19.8 38.81 0.08 13.1 97 1.4 848 * PALSON DRUG 75 3.76 0.09 11.7 38.81 0.08 19.8 38.81 0.08 13.1 97 1.4 848 95.39 116 116 122 UNI SANKYO 49 2.83 0.07 7.5 38.53 0.08 31.2 38.53 0.08 23.6 106 0.4 841 * UNI SANKYO 49 2.83 0.07 7.5 38.53 0.08 31.2 38.53 0.08 23.6 106 0.4 841 117 117 112 PSYCHOTROPICS 202 3.41 0.08 5.2 37.33 0.08 10.4 37.33 0.08 4 89 0.8 816 IMS, ALL RIGHTS RESERVED
  • 10. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 10 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% * PSYCHOTROPICS 202 3.41 0.08 5.2 37.33 0.08 10.4 37.33 0.08 4 89 0.8 816 118 118 115 ORDAIN HEALTHCARE 73 3.19 0.08 12.1 36.06 0.08 41.2 36.06 0.08 33.4 114 2.4 788 * ORDAIN HEALTHCARE 73 3.19 0.08 12.1 36.06 0.08 41.2 36.06 0.08 33.4 114 2.4 788 119 119 121 SHINE PHARMA 92 2.89 0.07 5.1 35.26 0.08 30 35.26 0.08 22.7 105 0.2 770 * SHINE PHARMA 92 2.89 0.07 5.1 35.26 0.08 30 35.26 0.08 22.7 105 0.2 770 120 120 117 INDI PHARMA 35 2.96 0.07 1.1 34.38 0.07 10.3 34.38 0.07 4.3 89 0 751 * INDI PHARMA 35 2.96 0.07 1.1 34.38 0.07 10.3 34.38 0.07 4.3 89 0 751 95.78 121 121 116 GROUP 54 3.09 0.08 4 34.33 0.07 18.1 34.33 0.07 11.5 96 0.2 750 * GROUP 54 3.09 0.08 4 34.33 0.07 18.1 34.33 0.07 11.5 96 0.2 750 122 122 118 OBSURGE BIOTECH 69 2.96 0.07 10.2 34.09 0.07 10.5 34.09 0.07 4 89 4.6 745 * OBSURGE BIOTECH 69 2.96 0.07 10.2 34.09 0.07 10.5 34.09 0.07 4 89 4.6 745 123 123 124 RELIANCE 101 2.73 0.07 49 31.51 0.07 130.6 31.51 0.07 119.3 188 4.3 689 * RELIANCE 101 2.73 0.07 49 31.51 0.07 130.6 31.51 0.07 119.3 188 4.3 689 124 124 136 RECKITT BENCKISER 12 2.26 0.06 -11.7 31.19 0.07 -7.1 31.19 0.07 -12.5 75 681 RECKITT BENCKISER 12 2.26 0.06 -11.7 31.19 0.07 -7.1 31.19 0.07 -12.5 75 681 125 125 126 GALPHA LABS 96 2.67 0.07 10.7 30.86 0.07 14.5 30.86 0.07 8 93 0.9 675 * GALPHA LABS 96 2.67 0.07 10.7 30.86 0.07 14.5 30.86 0.07 8 93 0.9 675 96.12 126 126 127 LUNDBECK 6 2.65 0.07 9.2 30.59 0.07 9.7 30.59 0.07 3.3 89 669 + LUNDBECK 6 2.65 0.07 9.2 30.59 0.07 9.7 30.59 0.07 3.3 89 669 127 127 123 TALENT 92 2.79 0.07 10.1 30.25 0.06 15 30.25 0.06 8.3 93 4 661 * TALENT 92 2.79 0.07 10.1 30.25 0.06 15 30.25 0.06 8.3 93 4 661 128 128 125 SHALAKS PHARMA 100 2.67 0.07 3 30.21 0.06 9.9 30.21 0.06 3.5 89 1.8 660 * SHALAKS PHARMA 100 2.67 0.07 3 30.21 0.06 9.9 30.21 0.06 3.5 89 1.8 660 129 129 131 CONCEPT PHARMA 95 2.41 0.06 -5.9 29.73 0.06 16.6 29.73 0.06 10.2 95 0.1 649 * CONCEPT PHARMA 95 2.41 0.06 -5.9 29.73 0.06 16.6 29.73 0.06 10.2 95 0.1 649 130 130 134 VHB LIFESCIENCES 100 2.35 0.06 -16.9 29.59 0.06 13.7 29.59 0.06 7.4 92 1.2 646 * VHB LIFESCIENCES 100 2.35 0.06 -16.9 29.59 0.06 13.7 29.59 0.06 7.4 92 1.2 646 96.45 131 131 139 ELAN PHARMA 32 2.19 0.05 -3.6 28.32 0.06 18.3 28.32 0.06 11.7 96 0.6 619 * ELAN PHARMA 32 2.19 0.05 -3.6 28.32 0.06 18.3 28.32 0.06 11.7 96 0.6 619 IMS, ALL RIGHTS RESERVED
  • 11. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 11 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% 132 132 135 SUNWAYS 88 2.33 0.06 -9.2 27.65 0.06 11.2 27.65 0.06 4.8 90 2.7 604 * SUNWAYS 88 2.33 0.06 -9.2 27.65 0.06 11.2 27.65 0.06 4.8 90 2.7 604 133 133 140 KARNATAKA ANTIBIOT 62 2.14 0.05 -3.8 27.61 0.06 31.4 27.61 0.06 24.2 107 603 + KARNATAKA ANTIBIOT 62 2.14 0.05 -3.8 27.61 0.06 31.4 27.61 0.06 24.2 107 603 134 134 133 YASH PHARMA 65 2.40 0.06 4.8 27.56 0.06 32 27.56 0.06 24.8 107 602 + YASH PHARMA 65 2.40 0.06 4.8 27.56 0.06 32 27.56 0.06 24.8 107 602 135 135 143 LINCOLN PHARMA 198 2.02 0.05 -8.3 27.32 0.06 12.2 27.32 0.06 6 91 4.8 597 * LINCOLN PHARMA 198 2.02 0.05 -8.3 27.32 0.06 12.2 27.32 0.06 6 91 4.8 597 96.74 136 136 129 MOLEKULE INDIA 52 2.47 0.06 14.5 26.96 0.06 54.5 26.96 0.06 46.5 126 0.8 589 * MOLEKULE INDIA 52 2.47 0.06 14.5 26.96 0.06 54.5 26.96 0.06 46.5 126 0.8 589 137 137 132 WINGS PHARMA 47 2.40 0.06 21.9 26.84 0.06 29.8 26.84 0.06 22.5 105 587 WINGS PHARMA 47 2.40 0.06 21.9 26.84 0.06 29.8 26.84 0.06 22.5 105 587 138 138 130 STRESSENBURG 17 2.42 0.06 24.9 26.21 0.06 25.1 26.21 0.06 18.2 101 0.8 573 * STRESSENBURG 17 2.42 0.06 24.9 26.21 0.06 25.1 26.21 0.06 18.2 101 0.8 573 139 139 142 BAXTER 20 2.07 0.05 -4.4 25.69 0.05 -8.3 25.69 0.05 -13.7 74 561 + BAXTER 20 2.07 0.05 -4.4 25.69 0.05 -8.3 25.69 0.05 -13.7 74 561 140 140 141 BENNET PHARMA 21 2.09 0.05 15.8 25.65 0.05 27.9 25.65 0.05 20.7 104 561 + BENNET PHARMA 21 2.09 0.05 15.8 25.65 0.05 27.9 25.65 0.05 20.7 104 561 97.02 141 141 137 EISAI PHARMA 8 2.25 0.06 14.3 25.16 0.05 26.9 25.16 0.05 19.8 103 7.5 550 * EISAI PHARMA 8 2.25 0.06 14.3 25.16 0.05 26.9 25.16 0.05 19.8 103 7.5 550 142 142 147 PARENTERAL DRUGS 84 1.87 0.05 -6.5 25.15 0.05 13.2 25.15 0.05 6.8 92 0.7 549 * PARENTERAL DRUGS 84 1.87 0.05 -6.5 25.15 0.05 13.2 25.15 0.05 6.8 92 0.7 549 143 143 128 SAMARTH PHARMA 80 2.63 0.06 57.6 24.35 0.05 73.3 24.35 0.05 63.7 141 2.3 532 * SAMARTH PHARMA 80 2.63 0.06 57.6 24.35 0.05 73.3 24.35 0.05 63.7 141 2.3 532 144 144 146 MEDO PHARMA 49 1.91 0.05 2.9 22.60 0.05 36.4 22.60 0.05 29.3 111 493 + MEDO PHARMA 49 1.91 0.05 2.9 22.60 0.05 36.4 22.60 0.05 29.3 111 493 145 145 155 SEAGULL LABS 211 1.59 0.04 -35.5 22.34 0.05 23.4 22.34 0.05 17 100 5.9 488 * SEAGULL LABS 211 1.59 0.04 -35.5 22.34 0.05 23.4 22.34 0.05 17 100 5.9 488 97.28 IMS, ALL RIGHTS RESERVED
  • 12. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 12 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% 146 146 145 HELIOS 88 1.96 0.05 12.2 20.81 0.04 36 20.81 0.04 28.6 110 3.1 454 * HELIOS 88 1.96 0.05 12.2 20.81 0.04 36 20.81 0.04 28.6 110 3.1 454 147 147 150 MOREPEN LABS 97 1.82 0.04 -0.2 20.55 0.04 13.9 20.55 0.04 7.6 92 1.5 449 * MOREPEN LABS 97 1.82 0.04 -0.2 20.55 0.04 13.9 20.55 0.04 7.6 92 1.5 449 148 148 138 AMRUTANJAN 10 2.19 0.05 -4.9 20.54 0.04 -6.3 20.54 0.04 -11.6 76 449 AMRUTANJAN 10 2.19 0.05 -4.9 20.54 0.04 -6.3 20.54 0.04 -11.6 76 449 149 149 158 STADMED PRIVATE 49 1.49 0.04 6.8 20.08 0.04 14.3 20.08 0.04 7.9 93 439 + STADMED PRIVATE 49 1.49 0.04 6.8 20.08 0.04 14.3 20.08 0.04 7.9 93 439 150 150 148 LEBEN LABS 41 1.86 0.05 59.2 19.69 0.04 37.3 19.69 0.04 29.8 111 430 LEBEN LABS 41 1.86 0.05 59.2 19.69 0.04 37.3 19.69 0.04 29.8 111 430 97.49 151 151 149 SH PHARMA 31 1.83 0.04 -4.3 19.64 0.04 12.1 19.64 0.04 6 91 5 429 * SH PHARMA 31 1.83 0.04 -4.3 19.64 0.04 12.1 19.64 0.04 6 91 5 429 152 152 165 ESKAG PHARMA 24 1.34 0.03 -23.3 19.38 0.04 20.9 19.38 0.04 14.3 98 423 + ESKAG PHARMA 24 1.34 0.03 -23.3 19.38 0.04 20.9 19.38 0.04 14.3 98 423 153 153 159 FRESENIUS KABI 27 1.47 0.04 7 19.13 0.04 1.1 19.13 0.04 -4.8 82 0.3 418 * FRESENIUS KABI 27 1.47 0.04 7 19.13 0.04 1.1 19.13 0.04 -4.8 82 0.3 418 154 154 156 VANGUARD 35 1.56 0.04 -2.5 18.60 0.04 4.9 18.60 0.04 -0.9 85 406 VANGUARD 35 1.56 0.04 -2.5 18.60 0.04 4.9 18.60 0.04 -0.9 85 406 155 155 153 GUFIC 63 1.72 0.04 36.3 18.54 0.04 32.2 18.54 0.04 24.6 107 3.1 405 * GUFIC 63 1.72 0.04 36.3 18.54 0.04 32.2 18.54 0.04 24.6 107 3.1 405 97.7 156 156 152 NOEL PHARMA 91 1.77 0.04 30.7 18.40 0.04 19.7 18.40 0.04 13 97 2.9 402 * NOEL PHARMA 91 1.77 0.04 30.7 18.40 0.04 19.7 18.40 0.04 13 97 2.9 402 157 157 166 MERCURY LABS 41 1.29 0.03 -12.3 17.55 0.04 17.8 17.55 0.04 11.1 95 0.1 383 * MERCURY LABS 41 1.29 0.03 -12.3 17.55 0.04 17.8 17.55 0.04 11.1 95 0.1 383 158 158 154 A.N.PHARMACIA 34 1.70 0.04 55.8 17.30 0.04 37.2 17.30 0.04 28.9 111 0.7 378 * A.N.PHARMACIA 34 1.70 0.04 55.8 17.30 0.04 37.2 17.30 0.04 28.9 111 0.7 378 159 159 164 ADONIS 18 1.37 0.03 -14.1 17.25 0.04 14.8 17.25 0.04 8.7 93 377 ADONIS 18 1.37 0.03 -14.1 17.25 0.04 14.8 17.25 0.04 8.7 93 377 160 160 161 JAWA 48 1.46 0.04 4.5 17.20 0.04 18.9 17.20 0.04 12 96 1.8 376 IMS, ALL RIGHTS RESERVED
  • 13. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 13 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% * JAWA 48 1.46 0.04 4.5 17.20 0.04 18.9 17.20 0.04 12 96 1.8 376 97.89 161 161 151 BAN LABS. 36 1.78 0.04 14.2 16.97 0.04 43.9 16.97 0.04 36.2 117 371 BAN LABS. 36 1.78 0.04 14.2 16.97 0.04 43.9 16.97 0.04 36.2 117 371 162 162 157 GLAND PHARMA 30 1.50 0.04 32.1 16.54 0.04 37.8 16.54 0.04 30.1 112 4.4 361 * GLAND PHARMA 30 1.50 0.04 32.1 16.54 0.04 37.8 16.54 0.04 30.1 112 4.4 361 163 163 163 SYNCOM 111 1.37 0.03 -10.5 15.63 0.03 9.2 15.63 0.03 3.3 89 341 + SYNCOM 111 1.37 0.03 -10.5 15.63 0.03 9.2 15.63 0.03 3.3 89 341 164 164 162 FEM CARE PHARMA 42 1.38 0.03 0.1 15.36 0.03 1.9 15.36 0.03 -3.9 83 1.4 336 * FEM CARE PHARMA 42 1.38 0.03 0.1 15.36 0.03 1.9 15.36 0.03 -3.9 83 1.4 336 165 165 171 KEE PHARMA 35 1.14 0.03 -19.1 15.08 0.03 0.8 15.08 0.03 -4.9 82 329 KEE PHARMA 35 1.14 0.03 -19.1 15.08 0.03 0.8 15.08 0.03 -4.9 82 329 98.06 166 166 167 ALARSIN 14 1.26 0.03 3.5 14.71 0.03 12.1 14.71 0.03 5.6 91 321 ALARSIN 14 1.26 0.03 3.5 14.71 0.03 12.1 14.71 0.03 5.6 91 321 167 167 177 KLAR SEHEN 46 1.03 0.03 -0.2 14.65 0.03 20.9 14.65 0.03 13.9 98 320 KLAR SEHEN 46 1.03 0.03 -0.2 14.65 0.03 20.9 14.65 0.03 13.9 98 320 168 168 160 KON TEST CHEMICALS 36 1.47 0.04 43.7 14.07 0.03 -4.2 14.07 0.03 -9.8 77 307 KON TEST CHEMICALS 36 1.47 0.04 43.7 14.07 0.03 -4.2 14.07 0.03 -9.8 77 307 169 169 173 ACRON 31 1.13 0.03 -6.5 14.05 0.03 5.3 14.05 0.03 -1.3 85 0 307 * ACRON 31 1.13 0.03 -6.5 14.05 0.03 5.3 14.05 0.03 -1.3 85 0 307 170 170 170 STEDMAN 49 1.16 0.03 1 13.25 0.03 16.8 13.25 0.03 10.4 95 21.2 289 * STEDMAN 49 1.16 0.03 1 13.25 0.03 16.8 13.25 0.03 10.4 95 21.2 289 98.21 171 171 187 FLAMINGO PHARMA 23 0.93 0.02 -21.5 13.23 0.03 8.5 13.23 0.03 2.4 88 3 289 * FLAMINGO PHARMA 23 0.93 0.02 -21.5 13.23 0.03 8.5 13.23 0.03 2.4 88 3 289 172 172 168 MPI 20 1.25 0.03 13.2 13.21 0.03 21.6 13.21 0.03 14.6 98 289 MPI 20 1.25 0.03 13.2 13.21 0.03 21.6 13.21 0.03 14.6 98 289 173 173 179 MENARINI RAUNAQ 17 1.00 0.02 0.5 13.19 0.03 41.6 13.19 0.03 33.9 115 288 + MENARINI RAUNAQ 17 1.00 0.02 0.5 13.19 0.03 41.6 13.19 0.03 33.9 115 288 174 174 183 GUJARAT TERCE 78 0.97 0.02 -35 13.03 0.03 -5.3 13.03 0.03 -10.7 77 285 GUJARAT TERCE 78 0.97 0.02 -35 13.03 0.03 -5.3 13.03 0.03 -10.7 77 285 IMS, ALL RIGHTS RESERVED
  • 14. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 14 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% 175 175 176 PHARMA-TECH INDIA 39 1.04 0.03 9.4 13.00 0.03 32.4 13.00 0.03 24.7 107 284 PHARMA-TECH INDIA 39 1.04 0.03 9.4 13.00 0.03 32.4 13.00 0.03 24.7 107 284 98.35 176 176 180 ENTOD 62 0.99 0.02 2.3 12.78 0.03 33.1 12.78 0.03 25.7 108 0.9 279 * ENTOD 62 0.99 0.02 2.3 12.78 0.03 33.1 12.78 0.03 25.7 108 0.9 279 177 177 169 MERIDIAN LAB 51 1.25 0.03 31.7 12.60 0.03 35.1 12.60 0.03 27.4 109 0.1 275 * MERIDIAN LAB 51 1.25 0.03 31.7 12.60 0.03 35.1 12.60 0.03 27.4 109 0.1 275 178 178 172 FERRING PHARMA 19 1.13 0.03 4.2 12.59 0.03 22.4 12.59 0.03 15.5 99 275 FERRING PHARMA 19 1.13 0.03 4.2 12.59 0.03 22.4 12.59 0.03 15.5 99 275 179 179 178 SKYMAX LABS 24 1.01 0.02 25.2 12.31 0.03 -12.5 12.31 0.03 -17.5 71 18.2 269 * SKYMAX LABS 24 1.01 0.02 25.2 12.31 0.03 -12.5 12.31 0.03 -17.5 71 18.2 269 180 180 175 NULIFE 36 1.04 0.03 -0.5 11.86 0.03 9.2 11.86 0.03 3 88 259 + NULIFE 36 1.04 0.03 -0.5 11.86 0.03 9.2 11.86 0.03 3 88 259 98.48 181 181 191 LEO PHARMA 39 0.87 0.02 28.6 11.79 0.03 30.8 11.79 0.03 23.7 106 258 LEO PHARMA 39 0.87 0.02 28.6 11.79 0.03 30.8 11.79 0.03 23.7 106 258 182 182 199 THEMIS PHARMA 14 0.79 0.02 -27.9 11.59 0.02 2.7 11.59 0.02 -3 83 253 + THEMIS PHARMA 14 0.79 0.02 -27.9 11.59 0.02 2.7 11.59 0.02 -3 83 253 183 183 181 INGA 38 0.98 0.02 -1.9 11.07 0.02 13.7 11.07 0.02 7.3 92 0.4 242 * INGA 38 0.98 0.02 -1.9 11.07 0.02 13.7 11.07 0.02 7.3 92 0.4 242 184 184 182 AR EX 25 0.97 0.02 -3 11.04 0.02 15.6 11.04 0.02 9.1 94 5.3 241 * AR EX 25 0.97 0.02 -3 11.04 0.02 15.6 11.04 0.02 9.1 94 5.3 241 185 185 189 JUPITER 29 0.89 0.02 9.2 11.00 0.02 17.7 11.00 0.02 11.1 95 0.9 240 * JUPITER 29 0.89 0.02 9.2 11.00 0.02 17.7 11.00 0.02 11.1 95 0.9 240 98.6 186 186 185 PULSE PHARMA 43 0.96 0.02 1.5 10.97 0.02 11.9 10.97 0.02 5.4 90 240 + PULSE PHARMA 43 0.96 0.02 1.5 10.97 0.02 11.9 10.97 0.02 5.4 90 240 187 187 174 OPTHO REMEDIES 52 1.08 0.03 40.3 10.89 0.02 19.6 10.89 0.02 12.5 97 238 + OPTHO REMEDIES 52 1.08 0.03 40.3 10.89 0.02 19.6 10.89 0.02 12.5 97 238 188 188 195 LI TAKA PHARMA 42 0.84 0.02 3.7 10.72 0.02 -4.6 10.72 0.02 -10 77 234 LI TAKA PHARMA 42 0.84 0.02 3.7 10.72 0.02 -4.6 10.72 0.02 -10 77 234 IMS, ALL RIGHTS RESERVED
  • 15. LEADING CORPORATION BY VALUE INDIA-SSA PAGE 15 DECEMBER 2010 MONTH CUMULATIVE 12 MONTHS TO DATE RANKINGS NO CORPORATIONS Values In + Values In + Values In + % VALUES 12M CUM MON PROD Crores % -% Crores % -% Crores % -% EVOL N.P $ +000 12M.% 189 189 184 UNI LABS 12 0.96 0.02 -1.6 10.66 0.02 12.6 10.66 0.02 6.2 91 233 UNI LABS 12 0.96 0.02 -1.6 10.66 0.02 12.6 10.66 0.02 6.2 91 233 190 190 193 LA PHARMA 56 0.86 0.02 -6.5 10.32 0.02 25.3 10.32 0.02 18.5 102 226 + LA PHARMA 56 0.86 0.02 -6.5 10.32 0.02 25.3 10.32 0.02 18.5 102 226 98.72 191 191 200 REKVINA 41 0.78 0.02 -11.6 10.14 0.02 9.2 10.14 0.02 3 88 1.6 221 * REKVINA 41 0.78 0.02 -11.6 10.14 0.02 9.2 10.14 0.02 3 88 1.6 221 192 192 190 BDF 13 0.87 0.02 -21.1 10.07 0.02 -6.4 10.07 0.02 -11.6 76 220 BDF 13 0.87 0.02 -21.1 10.07 0.02 -6.4 10.07 0.02 -11.6 76 220 193 193 212 HINDUSTAN ANTIBIOT 31 0.64 0.02 -17.6 9.90 0.02 23.5 9.90 0.02 16.6 100 216 HINDUSTAN ANTIBIOT 31 0.64 0.02 -17.6 9.90 0.02 23.5 9.90 0.02 16.6 100 216 194 194 192 STERKEM 42 0.86 0.02 22.6 9.85 0.02 59.8 9.85 0.02 51.1 130 215 STERKEM 42 0.86 0.02 22.6 9.85 0.02 59.8 9.85 0.02 51.1 130 215 195 195 202 MARTIN HARRIS 5 0.75 0.02 -8.8 9.76 0.02 18.6 9.76 0.02 11.9 96 213 MARTIN HARRIS 5 0.75 0.02 -8.8 9.76 0.02 18.6 9.76 0.02 11.9 96 213 98.82 196 196 194 RESILIENT COSME 30 0.85 0.02 5.1 9.74 0.02 12.5 9.74 0.02 5.9 91 4.8 213 * RESILIENT COSME 30 0.85 0.02 5.1 9.74 0.02 12.5 9.74 0.02 5.9 91 4.8 213 197 197 196 TWILIGHT MARCANTIL 38 0.82 0.02 -3.6 9.73 0.02 -4.3 9.73 0.02 -9.6 78 4.5 212 * TWILIGHT MARCANTIL 38 0.82 0.02 -3.6 9.73 0.02 -4.3 9.73 0.02 -9.6 78 4.5 212 198 198 211 TIDAL LABS 32 0.64 0.02 -33.1 9.57 0.02 -7.4 9.57 0.02 -12.6 75 209 + TIDAL LABS 32 0.64 0.02 -33.1 9.57 0.02 -7.4 9.57 0.02 -12.6 75 209 199 199 204 EISEN PHARMA 19 0.74 0.02 -7.4 9.39 0.02 19 9.39 0.02 12.3 96 205 EISEN PHARMA 19 0.74 0.02 -7.4 9.39 0.02 19 9.39 0.02 12.3 96 205 200 200 216 LARK LABS 102 0.63 0.02 -37.2 9.24 0.02 -19.3 9.24 0.02 -24.1 65 202 LARK LABS 102 0.63 0.02 -37.2 9.24 0.02 -19.3 9.24 0.02 -24.1 65 202 98.92 201 201 206 NAVIL 36 0.70 0.02 -8.3 9.20 0.02 14.2 9.20 0.02 8.1 93 201 + NAVIL 36 0.70 0.02 -8.3 9.20 0.02 14.2 9.20 0.02 8.1 93 201 202 202 186 STIEFEL 23 0.93 0.02 721.1 8.97 0.02 18.5 8.97 0.02 10.7 95 196 STIEFEL 23 0.93 0.02 721.1 8.97 0.02 18.5 8.97 0.02 10.7 95 196 203 203 207 OZONE AYURVEDICS 8 0.68 0.02 -36.9 8.87 0.02 -9 8.87 0.02 -14.1 74 194 IMS, ALL RIGHTS RESERVED